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Sudden infant death syndrome (SIDS) has been the main cause of postneonatal 
(from 1 month to 1 year) infant mortality in western developed countries. SIDS can 
be defined as the sudden death of an infant or young child which is unexpected by 
history, and in which a full postmortem examination fails to demonstrate an 
adequate cause of death OBeckwith, 1970). 
Studies used to explore the mechanism of SIDS are of two main types: one 
type is epidemiological, the other is the investigation of risk factors, identified from 
epidemiological studies, in animal models. 
This study was designed to explore the overall hypothesis that a mechanism 
for SIDS may be linked to an interaction between hyperthermia, sleep state and 
cytokine production. The specific objective of this study was to investigate the 
effects ofhyperthermia and a surrogate of infection (administration of muramyl 
dipeptide) on cytokine production and mortality in a neonatal rat model. 
The present study was conducted in three parts. The first part was the control 
condition, the second part was the effect ofhyperthermia, and the third part was the 
effect ofhyperthermia combined with a surrogate for infection. In the first part, 50 
neonatal rats (aged 10 days) in three groups (C1, C2 and C3) were studied. The 
neonatal rats were kept with their mothers for two hours. All animals were given 
intraperitoneal injection of 0.1ml of 0.9% Normal Saline 30 min before the start of 
each experiment. Animals were killed 2 hours after the start of the experiment. 
Blood was collected by percutaneous cardiac puncture (C1), percutaneous cardiac 
puncture with anaesthesia (ketamine 55 mg/kg) (C2) and direct cardiac puncture 
with anaesthesia (ketamine 55mg/kg) (C3). Direct cardiac puncture and anaesthesia 
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(ketamine) did not significantly increase the production ofIL-ip and IL-6. 
In the second part, 100 animals were studied in five group with different 
temperatures (Tl-34^C, T2-39°C, T3-40^C, T4-4rC and T5-38^C). The animals 
were heated to the desired temperature for one hour and then kept at a baseline 
temperature of34°C for one hour. Animals were given an intraperitoneal injection 
of 0.1 ml 0.9% Normal Saline 30 min before the start of the experiment. Blood was 
taken after 2 hours if the animal was alive, or immediately if the animal died during 
the experiment, by direct cardiac puncture. Hyperthermia significantly increased the 
production ofIL-6 but not the production ofIL-ip. Hyperthermia significantly 
increased mortality. 
In the third part, 80 animals were studied into 4 groups (Ml-34�C，M2-39°C, 
M3-40°C and M5-38°C). The study design was the same as the second part but 
MDP 0.1 ml (25 nmol/animal) replaced the 0.9% Normal Saline 30 min before the 
start. MDP significantly increased the IL-ip production but not IL-6. MDP in 
combination with hyperthermia had a significant effect on mortality. 
Hyperthermia, or hyperthermia in combination with MDP, significantly 
increased the mortality rate in the neonatal rat. Although hyperthermia of this level 
would be expected to increase mortality, the additional effect ofMDP indicates that 
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Chapter 1 Introduction and Literature review 
1.1 Sudden infant death syndrome 
1-1.1 Definition 
The sudden infant death syndrome (SIDS) has a long history of more than 2,000 
years and has several different names. In 1969, Beckwith proposed the current 
definition of SIDS that is widely accepted. This definition is "the sudden death of an 
infant or young child which is unexpected by history, and in which a full 
postmortem examination fails to demonstrate an adequate cause of death (Beckwith, 
1970)”. 
1.1.2 Epidemiology ofsudden infant death syndrome 
For many years, sudden infant death syndrome was the commonest cause of death 
between 1 week and 1 year of age in the western developed world (Nelson et al., 
1989). 
From the mid-1980s, many epidemiological studies have been performed to 
look into SIDS and these demonstrated some characteristic features which are more 
frequently associated with the affected individual and his environment than with the 
general population (Gibson, 1992). They have found that a number offactors which 
can increase the risk of SH3S. These factors include prone sleep position, maternal 
and paternal smoking, overheating, bedsharing, not breast feeding, not using a 
dummy and use of pillows. Other factors such as young maternal age, low 
socioeconomic status, high parity, low birth weight, male infant, winter months and 
cold climates are also associated with SJDS (Nelson et al, 1989). 
Introduction 
All these factors can be categorized into factors related to the infant, the 
mother, childcare practice and the environment. It must be emphasized that the 
associations demonstrated in epidemiological studies do no necessarily imply that 
the relationship is causal. 
Infant factors 
Age distribution 
The peak incidence of SIDS occurs between 2 - 4 months. This is also a time when 
maternal antibodies the infant received before birth are waning and immune system 
is immature (Blackwell & Weir, 1997). 
Sex incidence 
SIDS is commoner in boys by a ratio of3:2. Seventy-three percent ofthe SDDS 
group were males as compare to 51% of controls (p < 0.01) (Lewak et al., 1979). 
Prematurity 
Between 14% and 20% of SJDS infants may be premature, and pre-term infants are 
very susceptible to apnoea of prematurity (Limerick, 1992). Compared to controls, 
SIDS babies are more likely to have a gestational age less than 40 weeks and a birth 
weight less than 3000 grams (Lewak et al., 1979). 
Mild respiratory tract infection 
Blackwell (1997) found that there were respiratory tract infection symptoms at least 
48 hours before death in over 90% of SEDS victims. 
No immunization or late immunization 
Studies found that infants who were not immunized for diphtheria, pertussis, and 




Bottle and breast feeding 
Bottle-feeding, or the lack ofbreast feeding, was reported to be significantly related 
to cot deaths in England in the 1960s. Breast feeding has been reported to reduce the 
risk of SIDS, and breast feeding reduces the risk ofboth respiratory and 
gastrointestinal infections (Pisacane & Grazino, 1994). 
Mother factors 
Maternal age 
The SIDS mothers were significantly younger and had shorter intervals since their 
preceding pregnancies. In addition they had fewer antenatal visits than controls 
(Lewak et al, 1979). 
Maternal smoking 
There is a strong association of SIDS with exposure to cigarette smoke, particularly 
maternal smoking (Blackwell & Weir, 1997). Smokers have been reported to be 
more frequently colonised by staphylococci and their pharyngeal cells are found to 
bind more of these bacteria. Flow cytometry has demonstrated that human epithelial 
cells from smokers bind significantly more S.aureus, B. pertussis, and several Gram-
negative bacteria (Saadi et al., 1996; el Ahmer & Mackenzie, 1994). 
Infant care practices 
The recognition that variations in infant care practice may significantly influence the 
risk of SIDS suggests that intervention in the form of advice to parents might lead to 
a reduction in the level of risk to which the infant population is exposed, and 
consequently to a reduction in the incidence of SH3S (Gibson, 1992). Two aspects of 
infant care, prone sleeping and overheating, have both been suggested as risk factors 
from case-control and population studies. 
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Prone sleeping position 
Prone sleeping position has been identified as an important modifiable SIDS risk 
factor. The prone sleep position is particularly dangerous when babies sleep in 
heated rooms, use soft bedding, heavy dressing, or have a recent illness (Ponsonby 
et a/., 1993; Fleming et a/., 1990). Bell (1996) found that in adults with a cold, nasal 
secretions contained a significantly higher number ofbacteria if the individual was 
in the prone position compared with the supine position. 
In some countries, advice that babies should not be slept prone, has resulted 
in dramatic falls in SIDS mortality rate of 50% or more, suggesting a causal link. In 
southern New Zealand there is clear evidence of a reduction in the mortality from 
SIDS following an intervention campaign to reduce the prevalence of the prone 
sleeping position in the community (Taylor, 1991). 
Hyperthermia 
Hyperthermia of infants can be caused by overdressing, too much bedding and room 
heating, which in turn can be influenced by weather (Nicholl & 0'Cathain, 1988). 
Bacon and colleagues (Bacon et al., 1979) suggested that excessive wrapping 
combined with mild infection could produce heatstroke and sudden unexpected 
death. Stanton (Stanton, 1984) found that 94% of34 SH3S victims were excessively 
clothed, in an unusually warm environment, hot and sweaty when found dead, or 
had an mild infective illness which would not be expected to cause death. 
Environmental 
Seasonal incidence 
A higher number of deaths in autumn and winter (60 - 65%), than in spring and 




There is an increase in mortality from SIDS associated with lower social class. In the 
United Kingdom the risk of SIDS is higher in the lower social classes IV and V 
(Golding & Peters, 1985). 
1.1.3 Pathologic findings 
Although, by definition, no cause can be found, there are a number of characteristic 
findings for SJDS at autopsy or on microscopic examination. Berry (1992) reviewed 
the pathological finding in SIDS. 
External examination 
This is important to exclude trauma and signs of suffocation. It shows that baby is 
well nourished and normally developed. Frothy blood-tinged fluid escaping from the 
nose and mouth is seen in about half of infants who die from SIDS. Postmortem 
hypostatic staining may be seen as an indicator of face-down position. It has 
assumed increased importance since prone sleeping has been shown to be a major 
risk factor for SIDS. Evidence of sweat in clothing may suggest overwrapping. 
Some babies with SH3S have an increased postmortem body temperature 
(Sunderland & Emery, 1981). 
Internal examination 
Petechial haemorrhages are seen in up to 80% ofbabies with SIDS and are typically 
found beneath the capsule of the thymus. Petechiae beneath the visceral pleura and 
epicardial petechiae are also commonly seen. Liquid heart blood is noted in 80%. 





Evidence of pulmonary oedema and congestion is found in infant deaths for many 
reasons. Minor inflammatory and infective changes of the respiratory tract are 
common in SIDS and may be important by contributing to overheating, apnoea, or 
sensitisation to bacterial toxins. Focal fibrinoid necrosis of the vocal cords, and 
persistent haemopoiesis in the liver have been seen in some studies (Berry, 1992). 
1.1A Theories of causation 
Many hypotheses and theories have been introduced to try to explain the cause of 
the SJDS. An early explanation ofSD3S was accidental suffocation by the mother or 
wet-nurse (Guntheroth WG., 1995). In 1889, Paultouf hypothesised that the large 
thymus, often found in victims of sudden infant death, might have a causal 
relationship (Russell-Jones, 1985). From then on, a number of theories and 
hypotheses, such as sleep apnoea, fulminating bacterial infection, milk 
hypersensitivity have been proposed (Guntheroth WG., 1995). It is generally thought 
that there is no single cause of SEDSD but several factors come together to cause 
death (Russell-Jones, 1985). 
Prone sleep position 
Recent research has shown a strong association between the prone sleeping position 
and SIDS. Mechanical causes of SIDS related to posture during sleep and upper 
airway obstruction have been postulated (McKendrick et al., 1992; Milner, 1987). A 
number of postulates have been proposed to explain the link between SIDS and the 
prone sleeping position. These include retention of C02, positional asphyxia, 
diminished arousal, and decreased heat loss in the prone position with increased the 
6 
Introduction 
risk ofheatstroke OSFelson etal., 1989; Ponsonby etal., 1993). 
Hyperthermia 
The higher metabolic rate is maintained at least until five months of age (Fleming, 
1992). There is some physiological evidence that infants of two to three months of 
age may be more vulnerable to heat stress than younger infants. It was proposed that 
the combination of excessive wrapping and mild infection could produce potentially 
fatal heat stroke in infancy (Bacon et aL, 1979). Five infants presented with fever, 
shock, convulsions, and a bleeding tendency with no obvious cause. The only 
constant finding was that they had all been excessively covered with bedding or 
exposed to external heating (Bacon et aL, 1979). Sunderland and Emery reported 24 
babies who had died suddenly and who had rectal temperatures measured 
immediately before refrigeration. Ten of these babies had temperatures in excess of 
38 °C and five greater than 40 °C. This suggested that hyperpyrexia might have been 
a factor in the aetiology of these SIDS deaths (Sunderland & Emery, 1981). 
Respiratory tract infection 
The peak incidence of the sudden infant death syndrome is in the winter, suggesting 
that cold might have a direct effect or perhaps act by producing conditions under 
which respiratory tract infections are more common (Peterson, 1980). 
Other theories 
Other theories include metabolic disorders, cardiovascular abnormalities, surfactant 
deficiency, prolonged expiratory apnoea and development abnormalities. 
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1.1.5 Associations ofSIDS with temperature and hyperthermia 
Hyperthermia is a state of thermoregulatory failure subsequent to the inability to 
dissipate a heat load at a sufficient rate (e.g. heat stroke), or excessive heat 
production with a normal rate ofheat loss (e.g. malignant hyperthermia) (El-Radhi 
AS. & Carroll JE., 1994). Hyperthermia my coexist with fever. 
SIDS, depends on two points, one is that the death is unexpected and the 
other one is that there is insufficient explanation of the cause of death. Although 
there is now strong evidence of a causal link between sleeping babies on their fronts 
and SIDS, there is no consensus as to the actual pathophysiological mechanism of 
death. There is evidence that many of the SK)S risk factors may be linked to factors 
which either reduce heat loss and/or increase metabolic rate (Nelson et cd., 1989; 
Ponsonby etal., 1993; Fleming etal., 1990). Factors linked to increase metabolic 
rate include low birth weight (KIGR), male sex, infant of 2-4 months. Factors linked 
to reduced heat loss include heavy dressing, head covering, soft bedding and prone 
sleep position. Infants sleeping prone will loose less heat than supine sleeping 
infants, and if the infant turns face down into the bedding or becomes totally covered 
by bedding then the risk of entering positive thermal balance becomes significant. 
Nelson and colleagues (1989) reported in that in southern New Zealand 81% of42 
SIDS victims were found dead in the prone position and 71% of these were noted to 
have their face down in the bedding or have their faces completed covered by 
bedding O^elson et al., 1989). This raised the question whether a baby found under 
bedclothes could suffer from either overheating or suffocation in this environment. 
Several authors have speculated that being submerged under bedclothes may directly 
cause death by asphyxia (Bass et al., 1986), and /or by lethal hyperthermia (Bass et 
al., 1986). Galland and colleagues (1994) undertook a study designed to explore the 
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micro-environment of sleeping newborn piglets covered by bedclothes, to determine 
the degree of asphyxiation and /or hyperthermia encountered. They found that 
piglets' body temperatures rose rapidly and it was considered likely that death from 
hyperthermia would result before dangerous levels of carbon dioxide or oxygen 
would appear. The data from this study would suggest that human babies submerged 
under bedclothes for any length of time would be more likely to succumb to the 
effects ofhyperthermia than asphyxia (Galland et al, 1994). A previously study 
showed when piglets aged 2-4 days were exposed to exogenous hyperthermia, they 
will increase their awake time by as much as 30% (Galland et aL, 1993). What was 
particularly remarkable about the subsequent experiments was that only one in three 
episodes ofhead-covering (8 of22 experiments) caused sufficient arousal to disrupt 
the recordings. This seemed to depend on the piglet, not the circumstances. Ethical 
guidelines determined that experiments be continued for 2 hours or terminated if 
rectal temperatures reached 42°C (normal piglet body temperature is 39.3 _39.7�C). 
A subsequent study was undertaken by the same group to mimic in the 
newborn piglet the premorbid and morbid environmental conditions ofSIDS victims 
found dead beneath the bedclothes (Galland et aL, 1997). The study compared 
physiological and pathological findings in the piglets with those findings seen in 
heatstroke and SDDS. Two groups of sedated animals were studied (12 control and 
12 heat stressed piglets). Results showed that death occurred without audible signs 
of distress or evidence of struggle at a temperature of 4.8 to 5.5°C above baseline 
within 180 to 360 minutes after head-covering. A further three of seven experiments 
undertaken on non-sedated heat stressed animals showed the same response. Death 
was preceded by respiratory alkalosis and progressive metabolic acidosis, 
respiratory fatigue, hypoxia and apnoea. Cardiac arrest followed respiratory arrest 
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within 5 minutes. Control animals were killed with phenobarbitone and post-mortem 
examination of heat stressed animals showed more petechiae (lungs, thymus and 
heart) and liver changes. However the heat stressed animals showed no evidence of 
coagulopathy. This might be anticipated as postmortem findings ofheatstroke 
patients will often show these findings. Overall the post-mortem findings in the heat 
stressed animals were very similar to those found in SEDS victims. This suggests 
that hyperthermia secondary to covering of the head with bedding can lead to death 
and some pathophysiological finding seen in postmortem are similar to those seen in 
heatstroke and SJDS victims. 
Other workers have shown that seven of eight malignant hyperthermia 
susceptible piglets died when subjected to a heat challenge which was well tolerated 
by controls. This indicates that susceptibility to hyperthermia death may differ 
(Denborough et al, 1996). 
Jardine and Haschke have tested the hypothesis that blankets covering a 
febrile infant animal could cause lethal hyperthermia through thermal entrapment 
(Jardine & Haschke, 1992). In order to observe certain physiological and anatomic 
aspects of severe hyperthermia and the pathophysiology and pathological changes 
accompanying hyperthermia death, they heated 10 piglets with a radiant heater until 
rectal temperature reached 41°C to simulate fever. The piglets were then covered 
with bedclothes until temperatures rose to 42°C. At this point the control animals 
were uncovered and their temperatures rapidly fell. The temperatures in the 
experimental group continued to rise until they died at a temperature of43.9 � 0.7°C 
after 96 � 43 minutes. The data show that lethal hyperthermia may result from 
thermal entrapment. Petechiae on the epicardium, and kidney were noted and there 
was white frothy pulmonary oedema fluid in the trachea. 
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These experiments clearly demonstrate that death from hyperthermia can 
occur with minimal anaesthesia, when piglets fail to arouse when placed in 
situations similar to those in which a number of SIDS victims are found. What 
however is less clear from these experiments is whether temperature alone is 
responsible to death or whether there are links with arousal and respiratory response. 
It is possible that the level of temperature causing death can be influenced by other 
SIDS risk factors such as pre-existing infection and exposure to cigarette smoke. 
Underlying individual differences and susceptibility may play a role. 
1.1.6 Associations ofsudden infant death syndrome with infection 
One of the many factors which have been implicated in the etiology ofSEDS is 
infection of the respiratory tract, particularly viral infection. Many infants had a mild 
respiratory virus infection the week before death, and viral infection are 
predisposing factors for bacterial colonisation and infection (Blackwell & Weir, 
1997). Minor inflammation of the respiratory tract is found in up to 60% ofbabies 
with SIDS and correlates with the isolation of micro-organisms (Krueger & Majde, 
1994). Likewise an increased incidence of pre-existing illness, particularly upper 
respiratory infection, has been noted (Fleming, 1992). 
There is serological evidence that some SJDS infants, particularly those 3 
months or younger, have been exposed to bacterial endotoxin (Oppenheim et al, 
1994). Several species of toxigenic bacteria or their toxins have been identified in 
SIDS infants (Blackwell et al., 1994). Two toxigenic bacteria were implicated in 
SEDS either by identification of their toxins in SIDS infants {Staphylococcus 
aureus)QsAz[2im et al., 1992; Murrell et al., 1993) or by epidemiological studies 
{Bordetellapertussis) (Nicholl & 0'Cathain, 1988; Lindgren et al, 1997). Toxins of 
11 
Introduction 
Staphylococcus aureus were identified in 36% SIDS infants. Morris and 
Haran (1987) hypothesised that SIDS is caused by toxins produced by overgrowth of 
nasopharyngeal bacteria following a viral infection. It is suggested that in the prone 
sleeping position, the clearance of upper respiratory tract secretions is reduced, 
leading to increased toxin production (Morris et aL, 1987). 
Other authors have similar hypotheses regarding the causation of SD3S 
suggesting that viral respiratory tract infections lead to a disturbance ofthe upper 
airway bacterial flora with overgrowth of staphylococci, streptococci and 
enterobacteria (McKendrick et al., 1992). Bell and colleagues undertook a study to 
test the hypothesis that the prone sleeping position is associated with accumulation 
ofupper airways secretions and increased bacterial growth in adults. Ten adult 
volunteers, aged from 19 to 35 years, with colds were divided into two groups. One 
group lay prone for one hour and then supine for one hour. The other group lay 
supine initially for one hour and then prone for one hour. At the end ofeach time 
period, a swab was passed into the nose and then placed in Stuart's transport 
medium. The result showed that nasal swabs after the prone period yielded higher 
bacterial counts than swabs obtained after the supine period (Bell S et al., 1996). 
The pyrogenic toxin of Staphylococcus aureus can kill previously healthy adults, so 
they might easily kill a small infant (Blackwell et al., 1992). 
There is evidence that viral infections can predispose to bacterial infections. 
Toxin can induce fever and this could enhance the amount of toxin produced by 
bacteria (Bohach et al., 1990). SIDS is linked with preceding mild upper respiratory 
infection and there is some evidence that staphyloccocal colonisation and 
staphylococcal toxin may be in some way related to this association. 
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1.1JAssociation ofsudden infant death syndrome with sleep state 
It has been suggested that prolonged apnoea may be the cause of SIDS 
(Steinschneider, 1972). Although this apnoea hypothesis has been discredited to a 
greater extent, it is still possible that SIDS may be linked to sleep state and arousal. 
Sleep is defined as unconsciousness from which the person can be aroused 
by sensory or other stimuli. There are two different types of sleep, one is slow wave 
sleep and another is rapid eye movement (REM) sleep. In the slow wave sleep, the 
brain waves are very slow. Most sleep during each night is of the slow wave variety. 
This is the deep, restful type of sleep. In the REM sleep state, the eyes undergo rapid 
movements despite the fact that the person is still asleep, the brain is quite active. 
This type of sleep is not so restful, and it is usually associated with vivid dreaming 
(Guyton AC. & Hall JE., 1997). 
Epidemiological studies have shown that environmental and caretaking 
factors have an effect on susceptibility to SIDS. (Coons & Guilleminault, 
1985)Arousal is an important protective response to prolonged apnea and other 
potentially life-threatening events during sleep (Mosko S. etaL, 1996). The majority 
ofnormal infants < 7 months of age fail to arouse from quite sleep in response to a 
hypoxic challenge, despite the presence of a hypoxic ventilatory response (Ward & 
Keens, 1992). Arousal is an important protective response during sleep, and arousal 
deficit is hypothesised to play a role in the etiology of SIDS (Mosko S. et al., 1996). 
All-night laboratory polysomnographic recordings were undertaken on 20 routinely 
bedsharing and 15 routinely solitary sleeping healthy breast-feeding Latino infants 
within the peak age range for SK)S. Recordings were done in both bedsharing (with 
mother) and solitary sleeping environments. The most important findings revealed a 
significant reduction in stage 3/4 sleep and inverse increase in stage 1/2 sleep on the 
13 
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bedsharing night compare to the solitary night, irrespective of routine sleeping 
arrangement (Mosko S. etal., 1996). 
Galland and colleagues (1996) studied the arousal response with the added 
challenge ofheat stress in the piglet model (n=10). Respiratory stimuli were applied 
during non-rapid-eye-movement (NREM) sleep. Heart rate, Sa02, intra-pleural 
pressure and inspired C02 and 02 were measured during normothermia and 
hyperthermia. The result showed that arousal from NREM sleep under adverse 
conditions ofhyperthermia shortened the arousal time from asphyxia stimuli. This 
was the opposite to what had been hypothesised. There was no change in the arousal 
threshold (Galland etal, 1996). 
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1.2 Overview of cytokines 
1.2.1 Definition 
Cytokines, can be defined as protein or glycoprotein factors secreted by cells of both 
monocytoid and lymphoid lineages. Lymphocytes produce lymphokines and 
monocytes or macrophages produce monokines (Bona & Bonilla, 1996). These 
proteins, termed cytokines, function as up- and down-regulators of immunologic, 
inflammatory, and reparative host response to injury. 
1.2.2 Classification of cytokines 
Over the past 25 years, cytokines, as soluble mediators of cellular cooperation, were 
initially identified and studied by examining the effect of cell culture supernatants 
on various cellular activities (Bona & Bonilla, 1996). Much research in recent years 
has helped to define more clearly the role of the various cytokines. It has been 
shown that some cytokines are secreted in the course of immunologic and 
inflammatory responses, but they also can be produced by keratinocyte, fibroblast, 
and other cells. 
Cytokines can be divided into four groups (Male & Roitt, 1996): 
(i) Interferons (O^N): e.g. EFN-alpha, n^N-beta and EFN-gamma 
(ii) Interleukins (E.): e.g. IL-1 to IL-15 
(iii)Colony-stimulating factors (CSF): e.g. Granulocyte-CSF, Macrophage-CSF and 
Granulocyte -Macrophage-CSF 
(iv)Tumour Necrosis Factor (TNP): e.g. TNF-alpha and TNF-beta 
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1.2.3 Biological activities 
Cytokine have been shown to have four important overall activities. These are: 
(i) Activation of the cells of the immune system. Cytokines are necessary for the 
stimulation ofT and B lymphocytes. For example IL-2 stimulates cytotoxic T 
cells and natural killer cells, and IFN-y activates macrophages. Some cytokines 
(IL-4, IL-2, IL-6) contribute to activation replication and differentiation ofB cell 
into plasma cells. 
(ii) Promotion ofhaematopoiesis. Some cytokines affect the proliferation and 
differentiation ofleukocyte progenitors in the bone marrow. For example D -^3 
acts on the pluripotent stem cell. 
(iii)Role in inflammation. Most cytokines contribute to the inflammatory process by 
activating lymphocytes and other leukocytes: IL-1 in particular has a more 
systemic role in the induction of the acute phase response following infection or 
injury, but U.-6 and TNF also make a contribution. 
(iv)Cytostatic and anti-viral activities. Tumour Necrosis Factor (lymphotoxin), and 
Interferons have the ability to inhibit cellular proliferation and stimulate tumour 
necrosis and regression in vivo (Reeves G. & Todd 1.，1991). 
Although there are four groups of cytokines, they have an inter-relationship between 
each other, which can be described as a network. This is demonstrated by the fact 
that different cytokines are required for each stage of a multi-step process, or by 
particular combinations of cytokines that are synergistic. Particular cytokines may 
induce the production of other mediators and some cytokines may inhibit the action 
of others (Reeves G. & Todd I., 1991). In this complex network, their activities often 
overlap considerably, and one cytokine may induce the secretion of other cytokines 
or mediators, producing a cascade ofbiologic effects (Oppenheim et cd., 1994). For 
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example IL-1 and TNF can induce IL-6 production. IL-1 also can promote the 
synthesis ofIL-3, IL-6 and TNF (Bona & Bonilla, 1996). 
Since the identification of cytokines, there has been a very large amount of 
research undertaken to better understand the molecular and biological activity of 
cytokines. Some studies show that temperature, sleep and infection are intimately 
linked to the cytokines network (Kmeger & Majde, 1994). Smoking also has been 
shown to influence the cytokines network. In this complicated relationship it appears 
that the main cytokines to influence, and be influenced by sleep, temperature, 
infection and smoking, are the cytokines IL-1, IL-6 and TNF. These cytokines are 
therefore discussed in further detail. 
Interleukin 1 
IL-lp is produced by many different cell types. These include monocytes, dendritic 
cells, Langerhans cells, endothelial cells, astrocytes, microglia, as well as 
keratinocytes and some B and T lymphocytes (Bona & Bonilla, 1996). This cytokine 
was originally described in the 1940s as a heat-labile protein found in acute 
leukocytic exudate fluid which when injected into animals or humans would produce 
fever and it was noted to be a activated by mononuclear phagocytes. IL-1 can be 
synthesised by mononuclear phagocytes, lymphocytes, keratinocytes, fibroblasts and 
other cells with an appropriate stimulus. Two types ofIL-1 (IL-la and IL-lp ) were 
reported. IL-lp is the predominant form ofEL-1 and the amount ofIL-ip in 
activated cells is usually 50-fold greater than the other. IL-la and IL-lp have the 
same surface receptors and share the same biological activities (Dinarello & 
Kmeger, 1986). There is a dramatic increase in IL-1 in response to infection, 
microbial toxins, inflammatory agents, production of activated lymphocytes, 
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complement, and clotting components. Both forms ofIL-1 can induce sleep, 
somnolence and systemic acute-phase response including fever, hepatic acute-phase 
protein synthesis, neutrophilia, hypoferremia, hypozincemia and increase levels of 
hormones (Dinarello & Krueger, 1986). IL-1 can also induce other cytokine 
synthesis, such as itself, IL-6 and TNF (Bona & Bonilla, 1996). 
Interleukin 6 
IL-6 is produced by T cells, B cells, macrophages, fibroblasts, chondrocytes, 
keratinocytes, endothelial cells, bone marrow stromal cells, mesangial cells, brain 
astrocytes and microglial cells, and follicular stellate cells of the anterior pituitary. 
IL-6 production is stimulated by several different mechanisms such as viral 
infection, bacterial products such as endotoxin, synthetic polynucleotides (poly-
inosine:cytosine), or other cytokines such as IL-1 or TNF. The variety ofIL-6 
producing cells and the stimuli which elicit secretion argue for an important role in 
inflammatory and immune response 
(Bona & Bonilla, 1996). 
IL-6 is a pleiotropic cytokine produced by a variety of cells including 
monocytes, macrophages, endothelial cells and fibroblasts (Calandra etal., 1991). 
n^-6 was found in the culture supernatant of Phytohaemoglutauin stimulated 
peripheral blood mononuclear cells (Muraguchi et al, 1981) or Purified protein 
derivative stimulated mononuclear cells infiltrated in the pleural effusion ofpatients 
with tuberculous pleurisy (Teranishi et al., 1982). It also can be produced by viral 
infection, bacterial products such as endotoxin or other cytokine such as IL-1 or 
TNF (Bona & Bonilla, 1996). IL-6 has multiple biologic activities, including 
inflammation, immune response, acute phase response and hematopoiesis (Hirano 
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T., 1992). In immune response, it has effects on most major effector cells of the 
immune system, including B lymphocytes, helper T lymphocytes, cytotoxic T 
lymphocytes and natural killer cells (Snick, 1990). Acute phase response is the most 
important physiologic effect. This is a systemic response to inflammation 
characterised by an altered pattern ofhepatocyte protein synthesis. The response is 
often associated with leukocytosis, fever, increased vascular permeability and 
altered concentration of serum metals and steroid hormones (Bona & Bonilla, 1996). 
Recent experiments investigating cytokines function in hematopoiesis have shown 
that IL-6 cooperates with EL-3 in enhancing stem-cell differentiation. Another 
important activity ofE^-6 in hematopoiesis is its effect on megakaryocytopoiesis. 
IL-6 also acts as a differentiation inducing factor for certain myeloid leukemic cells. 
In addition, IL-6 has been shown to increase body temperature (Akira et a/.�1990). 
Tumour Necrosis Factor (TNF) 
TNP is a 25 kDa nonglycosylated transmembrane protein when present on the 
surface of an activated mononuclear phagocyte (Bertagnolli MM, 1993). Activated 
monocytes and macrophages are the predominant source ofTNF (Bona & Bonilla, 
1996). Lipopolysaccaride (LPS) stimulation of activated mononuclear phagocytes is 
the most important mechanism ofTNF secretion (Bertagnolli MM, 1993). 
There are two types ofTNF, one is known as cachectin or TNP- a, first 
described as activite in the serum ofLPS-treated animals that was capable of 
inducing hemorrhagic necrosis of certain tumours. The other is lymphotoxin known 
as TNF-P, which is primarily a product of activated T lymphocytes (Oppenheim et 
al., 1994). TKF-a and TNF-P both bind to the same receptors on target cells and 
consequently have the same biologic activities. TNF has a wide range ofbiologic 
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act ivi t ies , i nc lud ing e n d o t o x e m i a and sepsis , h e m a t o p o i e s i s and cell d i f fe ren t i a t ion , 
ant iviral e f f ec t s , i m m u n o l o g i c a l and i m m u n o - r e g u l a t o r y roles 
(i) E n d o t o x e m i a and seps is Inves t iga tors found that high d o s e s o f T N F induce a 
cons te l la t ion o f h e m o d y n a m i c , pulmonary，metabol ic and pa thologica l 
c o n s e q u e n c e s ind i s t ingu i shab le f r o m e n d o t o x e m i a and sept ic shock (Tracey , 
19()1). In its most severe fo rm, it can cause d i s semina ted in t ravascu la r 
c o n s u m p t i v e c o a g u l o p a t h y thal prec ip i ta tes death in the atTected animal 
(ii) l,!emajLQj2gie_d§jLQ<ii^_lLdiffej:e�Jklk_r!. S tud ies in mice have s h o w e d that T N F is 
an impor tan i factor for hematopo ie t i c d i f fe ren t ia t ion for cells o f i h e myeloid 
l incage ( M y e r s MJ & Mur t augh Ml), 1995) 
(iii) AiujAira!^tIc .c ts TNf : reduces v i m s yield and virus induced cy topa iho logv ancl 
thc antiviral act ivi ty of TNI- is cnhanccd by IFN-y ( C a m p o s t ' / ‘ / / . , 1988) It can 
rcducc viral repl icat ion I NF has cy to toxic or cytosta t ic act ivi ty against soinc 
li imoiirs I n t r a \ c n o u s adminis t ra t ion o t ' T M . lcacl to fevcr. lc i ikocvtosis ancl an 
acu te phase response These ctVecis are syncruis i ic wiih 11,1 and II.-O 
(i\ ) ln i i iu jnoIogical and invmunoregulatorA rolcs TNI. s t imula tes i i iacrophagc 
ilitTcrcniiaiioii and aci ivai ion. ami cnhanccs prol i fcra tuin arul iiitTcrcniialK>n ot' 
a c i i \ a l cd H cclls (lk>iia dc Bonilla.卜>("、> 
1.2.4 Cytokines and temperature 
As tk . scnbcd a K n c . cy iokincs can causc tc%cr. hut on ihc other hand, lcnipcra turc 
(h\ pc r thcrmia) can also inf lucncc thc produci ion o f c M o k i n c s l c\ cr is inciuccd b\ 
both cxoccno i i s p roducts likc cndoioxin . and c n d o u c n o u s cMokincs, mosi noiahls 
IL-1. II - < � a n J T M - { H u a n g ci u / . l^>>6) 
ln � > ^ ) : � . Bouchama and colkMgucs studicd paticnts u i t h hca is t rokc (n 38) to 
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determine plasma levels ofIL-ip, IL-6 and IFN-y and to examine the relationship 
between cytokine levels and severity ofhyperthermia, metabolic derangement, and 
clinical outcome (Bouchama et cd., 1993). Plasma IL-ip, IL-6 and IFN-y 
concentrations were measured by enzyme-linked immunosorbent assay in 28 
heatstroke patients at the time ofhospital admission (precooling) and after complete 
cooling. Measurements were also undertaken in 10 normal control subjects. Result 
showed that levels ofIL-lp, IL-6 and E^N-y were elevated in the heatstroke patients 
and JL-6 was correlated with severity of illness. It was suggested that these 
cytokines might play a role in the pathogenesis ofheatstroke. 
In 1995, Robins and colleagues assayed the plasma of patients exposed to 
whole body hyperthermia (WBH) for induction ofG-CSF, IFN-y, IL-la, IL-2, IL-3, 
IL-4, IL-6, IL-7, IL-S, IL-10, JLA1, IL-12. Patients were heated for 60 min ofWBH 
of 41.8 °C by radiant heat. Plasma was obtained before heating (15 min), at peak 
temperature, and after heating (2.5 hr, 5.5 hr, and 23.5hr). Results revealed the 
ability ofWBH to induce elevated plasma levels ofG-CSF, JL-lp>, K -^6, E^-8, IL-10, 
TNP- a within hours ofWBH. There are no effect on GM-CSF, JFN-y, DL-la, JL-2, 
IL-4, IL-7, IL-11, IL-12, M-CSF (Robins et al., 1995). 
In 1996, Haveman and co-workers conducted experiments to investigate 
cytokines levels in the serum of rats after both externally induce WBH and localized 
hyperthermia. Female rats, 8 to 10 weeks of age were used and WBH induced by 
submersion in a waterbath at 41.5 °C. For localized hyperthermia, the right hind leg 
of the rats was immersed in a thermostatically controlled waterbath, and kept at 
temperatures o f 4 3 � C , 44 °C, 45 °C or 46 X . IL-6, IL-1 and TNF were assayed and 
JL-l and JL-6 were found to be elevated after 41.5 °C WBH. No significant increase 
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in TNF levels was detected in any sample. IL-6 levels were enhanced 24 hr after 30 
min at 45 °C or 46 °C localized heat treatment (Haveman et al, 1996). 
IL-la, IL-ip and TNP-a can also cause fever indicating a feedback 
mechanism between cytokines production and fever generation (Kmeger & Majde, 
1994). 
1.2.5 Cytokines and infection 
Cytokines production is associated with infection, and current evidence shows, that 
cytokines are induced by a complex array of microbial products, inflammatory cells, 
factors released from injured tissue reactions and by other cytokines (Krueger & 
Majde, 1994). 
Calandra and co-worker in 1991, measured the levels ofIL-6 in 70 patients 
with established septic shock caused by gram-negative bacteria to determine 
whether, and for how long, IL-6 was detectable in the circulation ofthese patients. 
This was done to assess whether EL-6 levels were associated with clinical outcome 
and to examine the interplay between R.-6, TKF, IL-lp, and IFN-y. Serum was 
collected at study entry before the infusion of immunoglobulins and at day 1 and at 
day 10 in surviving patients. The results showed that IL-6 was present in the 
circulation of patients with septic shock due to gram-negative bacteria, and that IL-6 
concentration peaked near the onset of shock and decreased within 24 hours to 
undetectable levels. Levels ofEL-6 were correlated with those ofTNF but IL-6 did 
not correlate with either JLAp> or DFN-y. JL-6 had no useful role for predicting the 
clinical outcome of these patients (Calandra et al., 1991). 
Previous studies have shown that EL-6 increased in adult patients with sepsis 
(Hack & Degroot, 1989). A few studies have examined EL-6 production in children 
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with blood culture-positive sepsis and detected elevated levels of IL-6 compared to a 
control group (Sullivan et al, 1992; Groll et al., 1992; Heney et aI., 1992). 
1.2.6 Cytokines and smoking 
Smoking has been shown to influence the production of cytokines. Airway epithelial 
cells have been shown to synthesise a number of important multifunctional 
cytokines, including TNF- a, K>-lp (Devalia et al., 1993), IL-6 (Levine et al., 1993; 
Bedard etal., 1993) and E^-8 fNakamura etal., 1991). 
In 1996, Kuschner and co-workers studied the dose-response relationship 
between cigarette smoke exposure and pulmonary cell and cytokine concentrations 
in bronchoalveolar lavage (BAL). They measured BAL cells and BAL supernatant 
concentrations ofTNF- a, IL-ip, EL-6, IL-8 from 14 healthy smokers and 16 healthy 
non-smokers. They concluded that concentrations of macrophages, neutrophils, EL-
1P and EL-8 were elevated in the pulmonary microenvironment cigarette smokers in 
a dose-dependent manner (Kuschner et al., 1996). 
Recent studies ofBAL macrophages from smokers studied in vitro indicate 
that cytokine regulation in the lung may be altered by cigarette smoke exposure 
Some studies have found an increased concentration of pro-inflammatory cytokines 
in the pulmonary microenvironment of smokers. 
1.2.7 Cytokines and sleep/arousal 
"If you don't sleep enough you will get sick" and conversely, "if you are ill, sleep 
will help you recover". We often hear such suggestions from our loving parents or 
grandparents. Sleep is a common behaviour, so we do not pay too much attention to 
it. However, in recent years, a greater interest in sleep is being shown. The role of 
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temperature in infection has been explored to some extent but the role ofsleep in 
treating or preventing infection has attracted relatively little attention until more 
recently (Kmeger & Majde, 1994). Some experiments have been carried out to test 
the effect of sleep in animal models. Brown and his colleagues have studied the 
response of sleep-deprived mice to a primary infectious challenge (Everson CA, 
1998). The results suggested that there is immune suppression of the respiratory tract 
due to sleep deprivation. At least five independent laboratories have demonstrated 
that the ability of circulating immunocytes to produce immune response modifiers, 
such as IL-1, TNF, EFN- y and n,-6 in response to sleep deprivation (Krueger & 
Majde, 1994). Toth and Krueger recorded the sleep state ofrabbits after inoculation 
intravenously with gram-positive bacteria {Staphylococcus aureus). They found that 
non-rapid eye movement sleep (NREMS) greatly increased and rapid eye movement 
sleep (REMS) was inhibited (Toth & Krueger, 1988). One class ofimmune response 
modifiers tied to sleep regulation is the cytokines such as E^-ip and TNF- a. 
Inhibiting IL-1 or TNF with antibodies or antagonists directed against them inhibits 
spontaneous sleep in normal animals. It seems that basal levels ofIL-1 and TNF 
production are responsible, in part for normal sleep (McCrea et al., 1994). Krueger's 
research has focused on the relationship between sleep and infectious disease. Based 
on the above experiments, it is apparent that sleep loss can affect host defences, 
sleep is likely to be beneficial for recovery from infectious disease, and that IL-1 and 
TNF are involved in physiological sleep regulation. 
There is a close relationship between microbial products, cytokines, and 
sleep. Cytokines are likely key mediators of fever and sleep responses to infection. 
Microbial products responsible for sleep and fever response include bacterial 
muramyl dipeptides (MDP) and endotoxin. These microbial products induce sleep 
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and fever response in animal models. These substances share the ability to induce 
cytokines production. IL-1, TNP, acidic fibroblast growth factor (FGF) and IFN- a 
have been shown to be somnogenic and interact with factors such as the circadian 
rhythm and sleep deprivation (Krueger & Majde, 1994). IL-lp has been shown to 
increase NREM, as has WBH (Galland et aL, 1993). In rabbits, acidic FGF increases 
NREM sleep and also elevates body temperature by l°C (Knefati et al., 1995). 
There is an inverse relationship between IL-lp and the frequency ofapnoea 
(Lindgren & Grogaard, 1996). IL-1 has been suggested to be the link between 
infection and SD3S by adversely affecting respiratory control and arousal 
mechanism during infection (Krueger et al., 1982; Gunteroth, 1989). However with 
high levels ofIL-ip, the episodes of apnoea were more likely to be severe (Lindgren 
& Grogaard, 1996). EL-ip injected intravenously or intratechally in piglets has been 
shown to increase the reflex apnoea response (Stoltenberg et aI., 1994). The main 
finding ofthis study was that infection from respiratory syncitial virus reinforces 
reflex apnoea in young infants. There was no correlation with IL-6 and apnoea. 
Hohagen (1993) and co-worker studied the relationship between EL-ip and 
n^N-y production and the regulation of sleep and wakefulness. Four healthy male 
volunteers were investigated. After one adaptation night, beginning at 8 a.m. in the 
morning, the EEG was recorded by means of a mobile long-term EEG and blood 
samples were drawn every 45 min for a 24 hour period for the analysis ofIL-ip, 
TF^-y and cortisol. After 48 hours of incubation in the presence ofendotoxin 
Salmonella typhimurium, IL-ip and IFN- y levels were measured. The results show 
the capability of cultured blood cells to produce cytokines upon endotoxin challenge 
to be at a maximum around the time of sleep onset and during the first hours of 
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sleep, declining during the night to a minimum level in the morning hours. The 
results indicate that the cytokines IL-ip and IFN - y may play a role in sleep 
regulation (Hohagen etal., 1993). 
Summary 
Although the cytokines network is highly complex and still incompletely 
understood, it appears from the foregoing that there are clear links with this system 
and factors shown to increase the risk of SIDS. In particular IL-ip and TNF- a are 
released by passive and active hyperthermia, smoking and infection. In addition they 
are somnogenic and increase the amount ofNREM sleep. There is some evidence 
that IL-ip may increase the severity of apnoeas (Lindgren & Grogaard, 1996). It is 
therefore plausible that an infant, at a vulnerable developmental age, enters positive 
thermal balance by virtue of the prone sleep position, soft underbedding, heavy 
clothing and/or room heating and that this will increase production ofIL-ip, TNF-a 
plus/minus other cytokines. If the levels of these cytokines are already high or ifthe 
body has been previously primed as a result of a recent upper respiratory infection or 
parental smoking behaviour, then this combination may result in levels ofcytokines 
sufficient to increase NREM sleep, suppress arousal and increase the severity of 
apnoea should this occur as part of the developing hyperthermia. 
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1.3 Hypothesis and aims of the study 
The overall hypothesis is that a mechanism for death in the sudden infant death 
syndrome is linked to an interaction between hyperthermia, sleep state and cytokine 
production. Epidemiological studies have shown associations between SIDS and 
prone sleep position, overheating, soft under bedding, maternal cigarette smoking 
and recent upper respiratory tract infecton. Of these risk factors, prone sleep position 
is the most important. Prone sleep position will reduce heat loss and some animal 
studies have shown that hyperthermia secondary to covering the head with bedding 
can cause death. Hyperthermia can release cytokines and these cytokines are 
involved in physiological sleep regulation and they have effects on arousal from 
sleep and severity of apnoea. 
Based on these associations, the specific hypothesis of this study was that 
hyperthermia and a surrogate for infection (Muramyl dipeptide) would influence 
cytokines production and mortality in a small animal model (neonatal rat). 
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2.1 Overview of methods in piglet experiments 
As already discussed, two groups of workers have studied the possible effects of 
hyperthermia in animal models in relation to SIDS using neonatal piglets (Galland 
and Jardine). Galland and colleagues undertook a number of experiments on 
neonatal piglets looking at various aspects related to thermal stress and breathing 
(Galland etcd., 1994; Galland etal., 1997). In the study published in 1997, they 
studied two groups of sedated animals: a control group (n=12) and a heat-stressed 
group (n=12). In the control group, the piglets aged 4-5 days were put into a well 
insulated sleeping bag secured around the neck which maintained the rectal 
temperature between 39.3 and 39.7�C provided the environmental temperature was 
kept at 25 °C (baseline conditions). In the control group, sleep at these baseline 
conditions continued for 4 hours and was then followed by induced death 
(pentobarbitone, 150 mgy'kg i.a.). On the other hand , in the heat-stressed group, the 
age matched piglets slept under baseline conditions for 1 hour and then their heads' 
were loosely covered with bedding materials until spontaneous death occurred 
approximately 3-4 hours after covering. At 2-3 days ofage animals were 
anesthetized with halothane (1-1.15%) and using sterile techniques a catheter was 
implanted in the right carotid artery and tunelled subcutaneously to exit at the right 
shoulder (arterial catheterization). In the main experiments animals were lightly 
sedated with chloral hydrate (100 mg/kg orally) and prepared for the experiments 30 
min later. Ifthe animals awoke during the experiments for more than 2 minutes with 
audible signs ofdistress, they were removed from these experiments. Following 
these experiments, further 7 animals aged 2-3 days were studied according to the 
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heat stressed protocol but without sedation and without prior surgical procedures. 
The results indicated that hyperthermia secondary to covering of the head with 
bedding can lead to death and that a significant proportion of the animals did not 
arouse prior to death despite having only light or no sedation. It was also noted that 
the pathophysiological findings seen at post-mortem were similar to those seen in 
heat stroke and SIDS (Galland etal., 1997). 
In other main study dealing with hyperthermia in relation to SJDS in an 
animal model, Jardine and Haschke set out to test the hypothesis that blankets 
covering a febrile infant animal could cause lethal hyperthermia through thermal 
entrapment (Jardine & Haschke, 1992). The study also aimed to observe the 
physiological and anatomical aspects of severe hyperthermia. Ten weanling piglets 
aged 2-3.5 weeks were anaethetised with 100% oxygen and 4% halothane and then 
maintained with dry room air and 1-1.5 % halothane administered by face mask. 
They were then warmed by a radiant heater to a rectal temperature of41�C to 
simulate a fever. Animals in the experimental and control groups were then removed 
from the heater and covered with ordinary infant blankets (to a thickness o f � 3 cm). 
Endogenously produced heat then caused the animals' body temperature to rise 
further and when the temperature reached 42�C, the control animals were 
uncovered. After uncovering, the control animals' temperatures rapidly fell and 
returned to a normal body temperature. Animals in the experimental group were kept 
covered until they expired from hyperthermia, which occurred at a mean 
temperature of 43.9°C after a mean time of 96 minutes. 
These two experiments show that lethal hyperthermia may result from 
thermal entrapment, similar to an infant lying under bedclothes. One experiment 
used anaesthesia, whereas in the other used light sedation or no sedation. 
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2.2 Pilot study design 
These two previous experiments suggest that the neonatal piglet might have been the 
preferred animal for this study. The ratio ofbody mass to body surface area in the 
neonatal piglet is similar to that of a human infant (Jardine & Haschke, 1992). 
Newborn piglets also have similarities to the human infant in terms of sleep state 
development and cardio-respiratory control (Galland etal., 1994). The skin ofthe 
neonatal pig has some similarities to human skin, although pigs do not sweat in 
response to a thermal stimulus (Ingram, 1967). 
However we decided to try to establish a small animal (neonatal rat) model 
and at the same time try to use conditions similar to those used in the neonatal piglet 
experiments described above. There were several reasons for deciding to use the 
neonatal rat model. First it was a question of cost. Setting up the model using the 
neonatal rat would be significantly less expensive than setting up a model using 
neonatal piglets. Second was the fact that no kits to assay cytokine in piglets could 
be identified. Third it was hoped that if this animal model could be shown to be 
useful then future experiments using manipulations of oxygen and carbon dioxide 
and other parameters would be easier to carry out. However it was also recognised 
that the neonatal rat would be more difficult to monitor than the neonatal piglet. 
2-2.1 Study Groups 
It was initially decided to try to modify the experimental design used by Jardine and 
Haschke. In addition it was planned that two sets of experiments would be 
undertaken. The first set of experiments would be without pre-treatment with 
lipopolysaccharide (LPS) and the second set of experiments with pre-treatment with 
LPS. The administration ofLPS would stimulate endogenous cytokines production. 
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In the first set of expe r imen t s it w a s p roposed that the re wou ld be 4 g r o u p s with 10 
neonata l ra ts in each g roup . Based on the piglet exper iments , it w a s initially p lanned 
that the dura t ion of expe r imen t s would be for 4 hours. 
(i) T h e control g r o u p would remain at a t empera tu re o f 3 7 ° C for 4 hours 
(ii) A first heat stressed g r o u p would be heated to a t empe ra tu r e o f 4 P C for 4 hours 
(ii i)A second heat s tressed g r o u p would be heated to a t empera tu re o f 4 1 ° C and then 
c o v e r e d / w r a p p e d to reduce heat loss until t empera tu re reached 42°C. They 
would then be uncovered or unwrapped . 
( iv )A third heat stressed g r o u p would be heated as for the second heat stressed g roup 
but would remain covered until the t empera tu re increased to 43°C. 
It was proposed that the exper iments would be under taken wi thout anaesthesia based 
on the fact that Gal land had used cither light sedation or no sedation, and a 
s ignif icant propor t ion o f a n i m a l s studied had shown minimal or no arousal 
H o w c v c r the exper iment would be terminated i f t h e animal b e c a m e aroused or 
distressed 
The scconcl siagc o f i h c study would include another tbur uroiips o f a n i m a l s 
similar to tlioso above bul each g roup would bc preircated u i i h a closc o f l . P S to 
indiicc e n d o g e n o u s cviokinc produciioFi U>S is ihe niajor coniponcni o t ' ihc ccll 
wall o f u r a n i i icual i \c hactcria and sliiclics havc shown that ii can inducccl IL-1. IL-6 
aikl r \ I - product ion 
l-igurc 1 shows thc propcKscci study set iip l or cach cxpcrinicnt . ihc nconalal 
rat was placed in ihc pcrspcx box and placcd on insulaiinu material Beneath the 
animal u a s a hoating plate linkccl to a icmpcraiure controller i scc bc!ou ) 
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Figure 1 Proposed study set up (PT = Plate temperature, NT = Nest 
temperature, BT = Body temperature, ATI = Ambient 
temperature 1，AT2 = Ambient temperature 2，HR = Heart rate, 
0 2 = oxygen, C02 = Carbondioxide) 
A PowerLab system was used to record the animal (rectal and skin) temperature, 
environmental (nest and ambient) temperature and concentration of oxygen and 
carbon dioxide. It was initially hoped that it would also be possible to monitor the 
heart rate of the animal using a pulse transducer connected to the animals' tail and 
connected to the PowerLab system (Widdop & Li, 1997). However this method of 
measuring heart rate was described for use in fully grown rats and was found not to 
work on the neonatal rat. An attempt was also made to monitor ECG with adhesive 
electrodes. This was also unsuccessful and using a more invasive method of placing 
the electrodes was considered undesirable because of the possible effect that this 
might have on cytokine production. Likewise any measure ofEEG or EOG, and 
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respiratory rate did not appear to be feasible with the transducers and equipment 
available. 
2.2.2 Temperature controUer 
Whole body hyperthermia was induced by a temperature controller, loaned from the 
Department ofPhysiology, the Chinese University ofHong Kong (see Figure 2). 
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Figure 2 Temperature controller used in this study 
The temperature controller consisted of seven parts (components). They are T1 
controller, T2 controller, power driver, heater, sensor 1 conditioner, sensor 2 
conditioner and T3 changer controller (Figure 3). • T1 controller: responsible fo  th  lower t mperature set. 2 higher temperature set (advised that T2 > T1). 3 hangeover ontroller: T3 is the c angeov  emperature that is controlled and d tected by an external herm-couple sensor. Sens r 1 c nditio e : r sponsibl  t  d t ct th  temp ra ure of the heater p ate. 33
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• Sensor 2 conditioner: This is the sensor put into the animal's rectum (British 
BS1904 German DW43760 PT100). 
The temperature controller functious via a feedback system to maintain the animal at 
a desired temperature. The animal is placed on a heatable aluminium metal plate. 
The heat output to the metal plate is controlled by a feedback system based on the 
animal's actual rectal temperature and the desired rectal temperature. Whenever the 
temperature of sensor is higher than temperature of the indicator, the power will 
switch over automatically and can be controlled by the setting T1 knob. When the 
temperature of sensor is lower than the desired temperature, the heat plate power 
will raise the temperature automatically. 
T1 setting T1 controller 
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Figure 3 Schematic diagram of the temperature controller 
2.2.3 PowerLab system 
The PowerLab system is an easy-to use continuous data recording solution for both 
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life and physical sciences. It is a digital chart recorder, X-Y plotter, storage 
oscilloscope for biochemical, biology, chemistry, neurophysiology, pharmacology, 
physiology, psychology and zoology. This system comprises hardware and software 
for use on Mac and PC platform. Standard features include real-time polygraphic 
display of experimental data, fast data manipulation, on line computation on 
multiple input channels，convenient file storage and report standard data and result 
presentation and graphics. 
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Figure 4 PowerLab system (PowerLab 16s and the ML 205 gas analyser) 
In this study, the PowerLab 16s and the ML 205 gas analyser were used (Figure 4). 
The local company providing this equipment, Bioprobes fLtd), also provided four 
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locally assembled temperature recorders using a K type thermocouple (see Appendix 
for detailed specifications). These temperature sensors are attached to a small 
amplifier which is then directly connected to the PowerLab. In this study 8 channels 
were used to record the animal's rectal temperature, the heat plate temperature, the 
skin temperature, the power output, the nest temperature, the ambient temperature, 
the concentration of oxygen and carbon dioxide. All data were recorded for the 
duration of the experiment with a sampling rate of two per second. 
2.2.4 Experimental set up 
Before each recording period, the temperature probe connected to the temperature 
controller was placed into animal's rectum with lubrication to a distance of about 3 
mm. Outputs from the temperature controller (i.e. rectal temperature, power output 
and heating plate temperature) were in turn connected the PowerLab system. 
Another temperature probe was placed under the thigh to measure skin temperature 
and was directly connected to PowerLab. Visual monitoring of movement, breathing 
rate, skin colour and activity was made every 15 minutes and recorded manually on 
a chart. The full experimental set up is shown in Figures 5. 
2.2.5 Provisional ethical approval 
As noted, it was planned mimic the model of the neonatal piglets where no 
anaesthesia agents were used (Galland et al, 1997). However when ethical approval 
was sought from the Animal Research Ethics Committee of the Chinese University 
ofHong Kong, concerns were raised that animals exposed to a heat source would 
show signs of distress and it was questioned whether administration of an 
anaesthetic would alter the results significantly. After further discussion, the Ethics 
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Committee agreed to grant approval to conduct an initial pilot study consisting of 
twenty animals without anaesthesia. A progress report was then to be submitted to 
the Ethics Committee after this time. Application was also made to the University 
Laboratory Safety Office for safety approval. This was granted without any 
requirements for specific safety measures. A licence to conduct animal experiments 
was also obtained from the Department ofHeaIth, Hong Kong Government. 
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Figure 5 Full experimental set up 
2.3 Problems and results of pilot experiments 
To test out this proposed methodology, some initial pilot studies were required for 
the fol lowing reasons 
1 T o assess the practical feasibility of the proposed methods 
2. T o comply with animal Ethics Commi t t ee ' s requirements 
However it became obvious very quickly with the initial experiments with no 
37 
Materials and Methods 
anaesthesia, that animal activity during heating would make any monitoring very 
difficult. It was therefore decided that the initial 20 experiments would be conducted 
with anaesthesia. These experiments would be undertaken to determine the optimal 
age ofthe animals to be used (range 8 to 13 days), the appropriate dose of 
anaesthetic agent and the best method ofblood collection (direct or indirect cardiac 
puncture). During these pilot experiments, a number of practical problems were 
encountered which required revision of the study protocol. These problems are 
discussed in further detail. 
2.3.1 What is baseline body temperature ofneonatal rat? 
A number of references indicate that the body temperature of adult rat is 37-38�C. 
In the initial experiments, it was noted that the body temperatures of the neonatal 
rats, taken immediately after removal from their mothers, were significantly less 
than 37�C. In order to determine the baseline body temperature of the neonatal rat, 
12 neonatal rats aged 10-14 days were studied. Their rectal temperatures were 
recorded using a temperature sensor fBritish BS1904 German DW43760 PT100) 
connected the temperature controller. The temperature reading of the temperature 
controller was calibrated with temperature standard (see below) and the temperature 
output recorded through the PowerLab system. This temperature probe was placed 
into the animal's rectum immediately after removal from the mother. The 
temperature was also measured with the Bioprobe temperature sensor connected 
directly to the PowerLab system. The baseline body temperatures of these neonatal 
rats at 10 days of age ranged from 29.2°C to 33.5°C depending of the temperature 
sensor used (Table 1) and the temperatures were also seen to increase with age. It 
was decided to use a baseline temperature of34°C for the control group and not 
38 
Materials and Methods 
37°C. This experiment also highlighted the problems with calibration of the 
temperature reading obtained from the Temperature controller which was higher 
than the temperature detected by Bioprobe sensor. 
Bioprobe Sensor measured Rectal Temperature measured 
with PowerLab system from Temperature controller 
Mean SD Range Mean § 5 Range 
10days (n=12) 30.33 0.67 29.2-31.5 33.05 0.57 33-33.5 
11 days (n=12) 30.13 0.83 28.4-31.8 32.93 1.36 33-34.8 
12 days (n=9) 30.93 0.81 29.6-31.9 33.47 0.89 32.1-34.6 
13days (n=6) 31.88 0.37 32-32.3 34.47 0.70 34-34.6 
14days (n=3) 34.27 0.23 34-34.4 34.83 0.06 34.8-34.9 
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Table 1 Baseline body temperature of neonatal rats (n=12) aged 10-14 
days 
2.3.2 What type ofanaesthesic agent to use? 
The two anaesthetic agents considered were phenobarbitone and ketamine. After 
discussion with the staff on Animal House it was decided to use ketamine 
hydrochloride as this would be easier to administer and easier to monitor the animal. 
Ketamine hydrochloride is a cataleptoid anaesthetic of the phencyclidine group that 
is used in a wide range oflaboratory animal species (McCaethy, 1976). It is 
metabolised moderately rapidly and an incremental dose can be given to extend the 
period of anaesthesia (Flecknell, 1987). Ketamine produces immobility in most 
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species and can be administered by intramuscular, intraperitoneal and intravenous 
routes. It causes only moderate respiratory depression in most species and produces 
an increase in blood pressure. 
Although ketamine is used widely, it still has some undesirable effects. It can 
increase skeletal muscle tone, salivary secretion, and airway obstruction (Flecknell, 
1987). It is recommended that atropine at a dosage of 0.04 mg/kg ofbody weight be 
administered to minimise excessive bronchial and salivary secretion (Baker & 
Lindsey, 1980). The effect of increasing muscle tone may be a concern in relation to 
its use in the presence ofhyperthermia. There was also a concern that ketamine may 
have a direct effect on cytokine production. A search of the literature however only 
identified one publication suggesting a possible relationship between cytokines and 
ketamine (Nobuo J. & Kayoko S., 1997). 
2.3.3 What dose ofketamine to use? 
Based on local advice we initially used ketamine in a dose of 75 mg/kg in a neonatal 
rat aged 8 days. However the animal died after 20 minutes, suggesting that this dose 
may be too large. The dose was then reduced to 35 mg/kg in a 9 day old, but 
anaesthesia lasted only 30 minutes, with animal becoming active which made 
monitoring difficult. A dose 45 mg/kg to 55 mg/kg kept the animal sedated for 2 
hours, both with and without heating. At this level of anaesthesia, the breathing 
pattern of the animal was stable, regular and smooth. The respiratory rate was 
around 130-150 per minute. In addition, there was no problem with excessive 
bronchial and salivary secretions during pilot experiments so it was decided not to 
give atropine as well. 
40 
Materials and Methods 
2.3.4 Dilution of ketamine 
a. Ketamine solution (100 mg per ml) 0.5 ml 
b. Normal saline (0.9%) 9.5 ml 
c. Diluted ketamine solution = Solution a + Solution b (5mg/ml) 
Example of dose given: 
25gm neonatal rat to be given a dose of 55mg/kg need ketamine: 
...The amount of diluted ketamine needed: 
1 mg ketamine = 0.2 ml diluted ketamine solution 
25 gm X 0.055 mg/gram x 0.2 ml = 0.26 ml diluted ketamine solution 
2.3.5 Temperature calibration 
It became apparent during the pilot experiments that there were a number of 
problems with temperature calibration of the study equipment. There was a l—2�C 
difference between the body temperature as recorded by the Bioprobe temperature 
sensor connected to the PowerLab and the temperature of sensor connected to the 
Temperature Controller. Figure 6 shows the Bioprobe temperature sensors and 
amplifiers used. The difference also appeared to be non-linear. An experiment was 
therefore carried out to document the magnitude of the difference (Table 2). 
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Figure 6 Bioprobe temperature sensors and amplifiers connected directly 
to PowerLab system 
The equipment was then transferred to the Technical Services Unit (TSU) of the 
Chinese University for further testing and calibration. Two factors appeared to be 
involved in these variations of temperature measurement. The first factor was related 
to the calibration ofthe Temperature Controller. The Temperature Controller was 
calibrated against Temperature Standard machine that had also been made by TSU. 
This Temperature Standard machine had been calibrated against a commercial 
temperature standard (model 818P, Eurotherm Companies, UK) some years 
previously. The second factor was related to Bioprobe temperature sensors. A total 
of three Bioprobe temperature sensors were used in this study. When the 
temperature sensors from these three devices were placed in a well-stirred water 
bath they gave slightly different temperature readings. Shortly after the main study 
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started a second attempt to standardise and calibrate the various temperature 
measurements was made with the temperature standard machine. Details of this 
second process are presented later. 
Temperature of Temperature of Temperature 
Bioprobe sensor Temperature Controller Difference 
36.2 38 1.8 
37.1 38.3 1.2 
37.1 38.3 1.2 
37.1 38.3 1.2 
37.2 39.3 2.1 
37.2 38.4 1.2 
37.3 39.5 2.2 
37.5 39.8 2.3 
38 40.6 2.6 
38.1 40.7 2.6 
38.2 40.8 2.6 
38.2 40.8 2.6 
38.5 41.2 2.7 
38.9 41.9 3 
39.2 42.4 3.2 
39.2 42.4 3.2 
39.2 42.4 3.2 
39.5 42.8 3.3 
Table 2 Differences in temperatures recorded using Bioprobe 
temperature sensors and Temperature Controller temperature 
sensor 
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2.3.6 What is optimal neonatal rat age to use? 
We wished to select the age of the neonatal rat at which it would be developmentally 
equivalent to a three-month infant. In addition an important part of the experiment 
was to collect blood from the neonatal rat for cytokines assay. The blood collection 
process was more difficult in the very young rats and the blood volume required for 
the cytokine assays needed to be at least 1 ml. It was found that it was possible to get 
adequate blood in rat pups aged 10 days or over. At this stage little data had been 
located on the normal development of thermoregulatory processes in neonatal rat 
pups. Although thermoregulatory mechanisms and development in humans and rats 
probably differ significantly, it would have been ideal to determine i fa certain age 
ofneonatal rat would correspond most closely in terms of thermoregulatory 
development to a three-month old infant. Advice was sought on this from Dr 
Mortola ofMcGill University who commented that it is very difficult to make such 
developmental analogies (which are probably unjustified) and much depends on the 
parameter considered, and the analogy may not hold for other parameters. Dr. 
Mortola speculated that from a thermoregulatory viewpoint, a 6-7day old rat might 
be a better choice, in comparison to a three-month old infant as 6-7 day old rats can 
hold V02 in the cold for at least 1 hour. However such an assumption may not hold 
for other parameters, and possibly not even for thermoregulatory parameters other 
than thermogenesis (personal communication). However as it was not possible to 
obtain sufficient volume ofblood for cytokine assay in animals much less than 10 
days ofage. At this age sufficient blood could be collected to measure at least two 
cytokines and possibly three cytokines (IL-ip, R.-6 and possibly TNF- a). 
44 
Materials and Methods 
2.3.7 Which method ofblood collection to use? 
As the main focus of this study was the measurement of cytokines, it was important 
to ensure that enough blood volume for the cytokine assays were obtained. In animal 
studies, the choice ofblood collection method depends on the species, the amount of 
blood required and how essential it is to have blood that is free from contamination. 
Based on the above factors, it was decided that cardiac puncture was the best method 
ofblood collection. In the pilot experiments, difficulties were encountered in 
collecting blood by percutaneous cardiac puncture in neonatal rats aged 8 - 15 days. 
The technique is different to cardiac puncture of adult rat. Palpation ofthe cardiac 
impulse ofthe neonatal rat is more difficult which makes it more difficult to locate 
the best place to insert the needle. Using percutaneous cardiac puncture in these pilot 
experiments produced variable volumes ofblood. In some cases no blood could be 
obtained. In this method the rats were placed in dorsal recumbency, and 0.3 cm 
lateral from left sternal edge in the 4 or 5^ ^ intercostal space, a needle was inserted 
through chest wall to about 1 cm at 45 angle to horizontal. The needle was then 
slowly retracted and when a little blood is obtained, this position is maintained by 
holding it with the left hand, to slowly collect the blood required. In this method the 
left ventricle is ideally penetrated. During the initial pilot experiments it was not 
clear whether enough blood could be obtained by this method. 
Lewis and colleagues reported a technique for obtaining blood from mice. 
Blood was obtained from superficial blood vessels of tail with the incision made 
immediately after the mice had been exposed to an ambient temperature o f 4 5 � C 
(Lewis et al., 1976). This method was also tried but only several drops ofblood 
could be obtained. Gupta (Gupta, 1973) utilised a vacutainer system with a 21 gauge 
needle to successfully obtain blood by cardiac puncture in neonatal rats. In this 
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technique the rat pup is hand-held in dorsal recumbent position with the head 
downwards. The needle is slowly and gradually inserted into the thorax through the 
thoracic inlet until a trace ofblood is seen at the orifice of the needle within the 
collecting tube and held in that position until the desired amount is collected. This 
method was also tried but appeared not to be suitable for the present study due to 
inadequate blood volume obtained. 
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Figure 7 Method of direct cardiac puncture 
As a result of these difficulties staff at the Animal House advised that blood should 
be collected by direct cardiac puncture. This method ofblood collection would be 
able to offer a more stable blood volume for the cytokine assay. At the end of the 
experiment a second dose ofketamine was given if the animal was still alive. The 
animal was then place in the supine position and fixed. The abdominal wall ofrat 
was then cut horizontally and the diaphragm opened. The heart was thus exposed 
and if the animal was still alive was seen to be pulsating. The needle was then 
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inserted into the heart and the blood collected directly (Figure 7). Needles, syringes, 
and solutions were sterile and pyrogen free. 
2.3.8 What method to raise body temperature? 
It was initially proposed that the animals would be heated to 41°C and then wrapped 
or covered until the body temperature increased to 42°C. At this time one group of 
animals would be unwrapped or uncovered and the other would remain wrapped or 
covered. Figure 1 shows the intended method of achieving this. Foam rubber was 
used to construct several layers of insulation material. The lower layer would 
separate the animal from the heating plate and the upper layer could be lowered to 
cover the animal. When this method was tried out, it became apparent that the lower 
layer ofinsulation prevented the animal's temperature from increasing and lowering 
the upper insulation layer would obscure the experiment and make monitoring very 
difficult. It was thus decided that the temperature in the four groups would be 
modified only by the changing the setting of the Temperature Controller and 
heatable plate. To achieve this it was necessary to remove the thicker insulation 
cover over the heatable plate and replace this with a layer ofpaper towel. 
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2.3.9 Summary results 
The results of the pilot experiments are shown in Table 3. 
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Exp Age Body Wt Duration Rectal Temp Out come Ketamine Blood vol Bleeding 
(days) (gram) (hour) (degree) vol 
(mg/kg) 
T 8 W l 0.20 h r ” 3 ^ Die 0.25(75) Fail No 
2 8 17.5 2 hr 38.3 Alive 0.26(75) 0.2 No 
3 9 20 3.20 hr 38.3 Alive 0.30(75) Fail No 
4 9 17 2.15 hr 42.8 Die 0.12(35) Fail No 
5 10 20.1 1.30 hr 38.2 Alive 0.14(35) 0.2 No 
6 10 20.5 0.45 hr 42.4 Die 0.14(35) Fail liver 
7 11 23.6 2 hr 39.5 Alive 0.21(45) Fail No 
8 11 25.1 1.30 hr 40.8 Die 0.23(45) 0.3 liver 
9 12 28.3 1.55 hr 39.3 Alive 0.25(45) 0.4 No 
10 12 29.3 1.05 hr 40.8 Die 0.26(45) 0.4 liver 
11 13 30 1 hr 41.2 Die 0.27(45) 0.35 liver 
12 10 19.8 2.30 hr 38 Alive 0.18(45) 0.5 No 
13 10 18.2 2hr 39.8 Alive 0.16(45) Fail No 
14 10 20 1.30 hr 40.6 Die 0.18(45) Fail liver 
15 12 26.4 1.20 hr 41.9 Die 0.24(45) 0.32 liver 
16 16 43.5 1.45 hr 42.4 Die 0.39(45) 0.6 liver 
17 13 30.2 1.05 hr 42.4 Die 0.27(45) 0.7 liver kidney 
18 13 29.2 1.30 hr 40.7 Die 0.26(45) 0.6 No 
19 13 31.1 2.20 hr 38.4 Alive 0.28(45) 0.8 No 
20 15 36.3 1.10 hr 39.3 Die 0.33(45) 0.6 liver kidney 
, 
Table 3 Pilot experiments on 20 neonatal rats to determine in optimal 
age, dose of anaesthetic agent and blood collection method 
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2.4 Final study design 
Based on the results of the pilot experiments, a number of significant modifications 
in study design were required. It was decided to select neonatal rats aged 10 days 
and the baseline temperature of these animals was considered to be 34°C (not 3TC). 
Anaesthesia consisted ofketamine in a dose of 55 mg/kg. The duration ofeach 
experiment was shortened to 2 hours and blood was collected by direct cardiac 
puncture. This age and blood collection method would yield sufficient blood for 
measurement of two cytokines (IL-ip and IL-6). In a previous study animals were 
heated for 1 hour at 41.5�C by submersion of rats in a waterbath under anaesthesia 
with a halothane air mixture. The animals were then studied for a further 1 hour at a 
baseline temperature o f37�C (Haveman etal., 1996). Results ofthese experiments 
indicated that n,- lp peaked during WBH i.e. during the first hour ofheating at 41.5 
oQ whereas the IL-6 peaked after the first hour ofWBH i.e. during the second hour 
ofthe experiment. TNF-a did not increase in these experiments (Haveman et al., 
1996). Based on this information it was decided that the duration ofeach would be 
two hours (one hour heating and one hour at baseline temperature). It was 
considered that this duration would give sufficient time to demonstrate a cytokine 
(BL-ip and EL-6) response to hyperthermia. 
2A.1 Study animal 
Females Sprague-Dawley rats age of 10 days and pathogen-free were used in this 
study (n = 230). The original stock of rats was obtained from Australia and were 
mated at animal house of the Chinese University ofHong Kong. All experiments 
were performed on rats of20-40 gram body weight. The animals were caged 
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together in a temperature controlled room (21 °C) and provided with standard food 
and water. 
Neonatal rats were kept with their mother until they reached the desired age 
when they would be placed in the perspex box (12.5 x 22.5 x 19.5 cm) for the 
duration of the experiments (Figure 5). Before the experiment, neonatal rats were 
anaesthetised with ketamine hydrochloride by intraperitonium administration of55 
mg/kg ofbody weight. This resulted in sufficient anaesthesia for the rats to remain 
immobile and inactive for 2 hours. If the animal became active before completion of 
the experiment then a second dose ofketamine was given and this was recorded. 
2.4.2 Final Study Groups 
Twelve groups of animals were studied and there were 10 animals for each group. 
For each experiment, two neonatal rats were studied. The first animal was monitored 
via the Temperature Controller and had both rectal and skin temperatures recorded. 
The body temperature of this animal was controlled by the heat output from the 
Temperature Controller. The second animal had only skin temperature measured but 
was exposed to same level ofheating as the first animal. The inclusion ofthis 
second animal in the design was as a result of persisting difficulties in reliably 
obtaining sufficient blood for the cytokine assay. It was proposed that ifblood 
collection failed or was insufficient in the first animal, then blood from the second 
animal would be used. 
The twelve groups consisted of three control groups, five heated groups 
without Muramyl Dipeptide (MDP) and four heated groups with MDP. It was 
decided to use MDP rather than LPS because further review ofthe literature 
revealed reports linking SJDS to staphylococcal colonisation and infection 
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(Blackwell & Weir, 1997). MDP is a major component of the bacterial cell wall, 
especially in gram positive bacteria. The reasons for using three control groups are 
discussed in further detail below. 
Control groups 
All the animals in the control groups were kept with mother rat for two hours 
without heating and then taken from mother for collection ofblood. The difference 
between the control groups were as follows: 
Control group 1 (C1) (n=5x2) 
0.1 ml ofnormal saline was injected intraperitoneally to control for the injection of 
MDP used in the second set of experiments. Two and a halfhours after injection of 
the normal saline, blood was collected by cardiac puncture without anaesthesia. This 
control group was limited to only 5 animals and was included to control for the 
possible effect ofketamine on cytokine production. It was reasoned that a large 
effect ofketamine on cytokine production would be detected in this group. 
Control group 2 (C2) (n=10x2) 
Two and a half hours after injection of 0.1 ml of normal saline as for control group 
1, blood was collected by percutaneouscardiac puncture and with anaesthesia 
(ketamine 55 mg/kg). This group was to control for the possible effects of direct 
cardiac puncture on cytokine release. 
Control group 3 (C3) (n=10x2) 
Two and a half hours after injection of 0.1 ml of normal saline as for control group 
1, blood was collected by direct cardiac puncture and with anaesthesia (ketamine 55 
mg/kg). This group was to control for the sham heated group T1 (see below). 
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Temperature group 
Temperature group 1 (n=10x2) 
This was the sham heat-treated group without MDP. The 10 day old rat pup was 
taken from mother and given 0.1 ml normal saline intraperitoneally 30 min before 
the start of the experiment. This was to control for the injection ofMDP. The animal 
was then weighed and given ketamine 55mgy'kg. It was then placed in the heating 
box and maintained at 34�C for 2 hr. A second dose ofketamine (55mg/kg) was then 
given prior to euthanasia by direct cardiac puncture. 
Temperature group 2 (n=10x2) 
This was the first heat-treated group without MDP. The 10 day old rat pup was taken 
from mother and given 0.1 ml normal saline intraperitoneally 30 min before the start 
of the experiment. This was to control for the injection ofMDP. The animal was 
then weighed and given ketamine 55mg/kg. It was then placed in the heating box 
and maintained at 39°C for 1 hr and 34°C for lhr. A second dose ofketamine 
(55mg/kg) was then given prior to euthanasia by direct cardiac puncture. 
Temperature group 3 (n=10x2) 
This second heat-treated group without MDP was treated as for temperature group 2 
but maintained at 40�C for 1 hr and 34°C for lhr. 
Temperature group 4 (n=10x2) 
This third heat-treated group without MDP was treated as for temperature group 2 
but maintained at 41°C for 1 hr and 34°C for lhr. 
Temperature group 5 (n=10x2) 
This fourth heat-treated group without MDP was added to the study protocol at later 
stage. The group was treated as for temperature group 2 but maintained at 38°C for 1 
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hr and 34°C for lhr. The reason for adding this group later was related to problems 
with the calibration of the temperature controller described below. 
Temperature group 1M (n=10x2) 
This was the sham heat-treated group with MDP. The 10 day old rat pup was taken 
from mother and given 0.1 ml MDP intraperitoneally 30 min before the start ofthe 
experiment. The animal was then weighed and given ketamine 55mg/kg. It was then 
placed in the heating box and maintained at 34°C for 2 hr. A second dose of 
ketamine (55mg/kg) was then given prior to euthanasia by direct cardiac puncture. 
Temperature group 2M (n=10x2) 
This first heat-treated group with MDP was treated as for temperature group 2 
(39°C) but given MDP instead of normal saline at the start ofthe experiment. 
Temperature group 3M (n=10x2) 
This second heat-treated group with MDP was treated as for temperature group 3 
(40�C) but given MDP instead of normal saline at the start ofthe experiment. 
Temperature group 5M (n=10x2) 
This heat-treated group with MDP was treated as for temperature group 5 (38°C) but 
given MDP instead of normal saline at the start of the experiment. 
Figures 8a and 8b show sample experiments from each ofthe four 
temperature and four MDP groups. The heating plate, rectal, skin and ambient 
temperatures are shown and compared to the power output supplied to the heating 
plate. 
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2.4.3 Final ethical approval 
Although one of the initial intentions of this study had been to assess the effects of 
cytokines on arousal and mortality in the neonatal rat, it was apparent that for both 
practical and ethical reasons this would be difficult to achieve. A progress report 
was submitted to the Animal Ethics Committee of the Chinese University ofHong 
Kong summarising the results of the pilot experiments and seeking permission to 
continue with the study using the revised protocol. This approval was given. 
2.4.4 Muramyl dipeptide 
As noted above it was decided to use muramyl dipeptide (Wako Pure Chemical 
Industries, Ltd., Japan) to induce endogenous cytokines production rather than LPS. 
Muramyl dipeptide (MDP) C^-Acetyl muramyl-L-alanyl-D-isoglutamine) is derived 
from component ofbacterial cell wall peptidoglycan (Krueger & Majde, 1994). 
In Gram-positive bacteria, as much as 90% of the cell wall consists ofmurein or 
peptidoglyglycan. In Gram-negative bacteria, only 5 to 20% ofthe wall is 
peptidoglycan, the remainder being composed predominantly ofthe 
lipopolysaccharide (LPS) (Krueger & Majde, 1994). The MDP possesses pyrogenic 
and multiple immunologic activities (Adam & Lederer, 1984) in addition to 
somnogenic activity. A simple synthetic chemical analogue to this substance, N-
acetylmuramyl-L-alanyl-D-isoglutamine (or MDP for muramyl dipeptide), enhances 
SWS in rabbits (Krueger et a/., 1982), rats (Inoue et a/.’ 1984; Kadlecova & Masek, 
1987), cats (Krueger et cd., 1982), and monkeys (Wexler & Moore-Ede, 1984). 
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Muramyl dipeptide was first described as slow-wave sleep-promoting "factor S" 
(Fencl et al., 1971) and was noted to be a constituent of cerebrospinal fluid derived 
from sleep-deprived animals (Pappenheimer, 1983; Pappenheimer etal., 1975). 
More recently, factor S obtained from urine and brain was provisionally identified as 
a low molecular mass muramyl peptide (Krueger et al, 1982). 
Dilution ofMDP 
MDP 1 mg (equivalent to 1100 nmol) 
Distilled water 1.1 ml 
MDP stock solution 1000 nmol/ml 
IP. 4 nmolMDP/animalMDP solution (1): 
MDP stock solution 0.6 ml 
0.9% Normal Saline 6.0 ml 
75 aliquots oflOO ul 
Each aliquot = 8 nmol 
0.1 ml MDP solution (1) + 0.1 ml 0.9% NS = 0.2 ml 
Give 0.1 ml each animal (equivalent to 4 nmol) 
IP. 25 nmolMDP/animalMDP solution (2): 
MDP stock solution 0.5 ml 
divided into 10 aliquots of 50 ul (50 nmol) 
0.05 ml MDP solution (2) + 0.15 ml 0.9% NS = 0.2 ml 
Give 0.1 ml each animal (equivalent to 25 nmol) 
2.4.5 Recalibration of Temperature Controller 
Shortly after the main study started the TSU re-checked the calibration ofthe 
Temperature Controller and the Bioprobe temperature sensors using the TSU 
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Temperature Standard. During this procedure it was noted that the temperatures 
registered by the Bioprobe Sensor were much closer to temperatures measured with 
a digital thermometer and a mercury thermometer than were the temperatures 
measured by the TSU Temperature Standard machine. Based on this it was decided 
to standardise the Temperature Controller against the temperature readings obtained 
from the three Bioprobes sensors, digital thermometer and mercury thermometer. 
Due to these problems the temperatures in this study should be viewed as more 
relative than absolute. This problem with the calibration had the effect ofnullifying 
some ofthe results of the pilot experiments that had been used to determine the 
heating temperatures for the different groups. With the recalibrated equipment, a 
temperature of 41°C was found to be too high i.e. prior to recalibration this 
temperature would have been approximately 40°C. The animals died quickly and 
blood collection was often difficult. At this stage it was therefore necessary to add 
an additional temperature group to be heated to a temperature o f38�C for 1 hour and 
then at 34�C for 1 hour (groups T5 and 5M). 
2.4.6 Data collection 
Eight data channels were recorded on the PowerLab (rectal temperature, power 
output, heat plate temperature, skin temperature animal A, skin temperature animal 
B, ambient temperature, ambient O2 and ambient CO2). In addition manual 
recordings of activity, respiration and colour of skin and mucosa were made using 
the data sheet shown in Appendix 1. 
2.4.7 Blood collection and Storage 
After blood collection, the blood sample were put into the blank tube (model 4202 
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2.0ml/conical upright. Bio Plas, Inc., California). The tubes were then immediately 
placed at 4°C in a container. The temperature of centrifuge was set at 4 °C and the 
specimen spun at 3000 rpm for 10 minutes. The tubes were then removed from the 
centrifuge and replaced into the 4°C container. The upper column ofserum was then 
pipetted into different aliquots to avoid repeat freezing and thawing. 120 ul serum 
were placed into each aliquot, which were then stored at -70�C until cytokine assays 
were undertaken. 
2.4.8 Study timetable 
Appendix 2 shows the proposed study timetable. Pregnant female rats were ordered 
so that their litters would be 10 days old on the day ofthe experiment. A different 
litter was used each day and two to three experiments were conducted each day. It 
was proposed to conduct the experiments in the different treatment groups using the 
random timetable shown in Appendix 2. This schedule could not be followed as 
planned as there was a delay in obtaining the MDP. Due to delays already 
experienced in obtaining the final ethical approval it was decided to proceed with the 
experiments without MDP first and then complete the MDP experiments when the 
product arrived. 
2.5 Cytokines analysis 
2.5.1. Methods of Quantitative Enzyme Immunoassay 
Enzymes immunoassay has been applied to measure many substances, including 
carcino-embryonic antigen (CEA); steroid hormones; immunoglobulins; antibodies 
to bacteria, viruses and DNA; and allergens. The advantages ofenzyme 
immunoassays include, sensitivity, simplicity, stability of reagents, lack ofradiation 
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hazard, potential for automation and relatively inexpensive equipment (Stites DP., 
1984). The two most widely employed variants of enzyme immunoassay are 
competitive enzyme immunoassay and the enzyme-linked immunosorbent assay 
(ELISA). 
2.5.2 Base theories ofEnzyme-linked immunosorbent assay (ELISA) 
ELISA is a serologic test that utilises an enzyme labelled reagent. The advantages 
offered by ELISA are those of most antibody-labelled reactions, and include 
specificity, sensitivity, rapidity, inexpensive and safety (Barrett JT., 1988). The 
labelled reagents used are stable and are easily stored for long periods oftime 
without loss of activity. Multiwell microtitre plates allow large numbers ofsamples 
to be assayed (Voller & Bidwell, 1974). As a result, ELISA has been extensively 
applied both for the detection of antigens and antibodies in human and veterinary 
infectious disease and immunology (Schuurs & Vanweemen, 1977). 
The base theory ofELISA is the binding process of antigen to specific 
antibody. It can be used to measure the amount of antigen in a biological fluid 
(Clancy J., 1998). 
A sample o f b i o l o g i c a l fluid such as blood serum is placed into a solid 
support vesicle that has been coated with an ant ibody that specif ical ly recognises a 
specif ic part of some antigen found in blood. This ant igen b inds to the coating 
ant ibody and is detected by the addition of another ant ibody that specif ical ly 
recognises another specific part of the antigen that is bound to the coating antibody. 
This detect ing ant ibody is linked to an enzyme that specif ical ly reacts with a 
substrate that is then added to the reaction mixture to yield a coloured solution. The 
colour intensity of the solution is indicated of the amount o f a n t i g e n in the fluid 
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sample (i.e. the darker the colour, the greater the amount of antigen present in the 
assay sample). Thus the binding of an antigen to a specific antibody provides the 
physician with the means to measure the concentration of a specific antigen in 
biological fluids (Clancy J., 1998). 
2.5.3 Procedure for cytokines assay 
In each of the experiments, blood collected by cardiac puncture or direct cardiac 
puncture, was spun at 3,000 rpm for 10 min maintained 4 °C. Serum were divided 
into three different aliquots, each aliquot contained 120 ul , and stored at - 70 °C for 
subsequent assay for D^_ip, JL-6 and using enzyme-linked immunosorbent assay 
(ELISA) Kits (Biosource International, Inc. USA) (Figure 9). 
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Figure 9 Enzyme-linked immunosorbent assay (ELISA) Kits (Biosource 
International, Inc. USA) 
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IL-ip assay 
All reagents were allowed to reach room temperature before use. All liquid reagents 
were gently mixed prior to use. 
• 100 ul of standard diluent buffer was added to zero wells. The wells reserved for 
the chromogen blank were left empty. 
• 50 ul of standard diluent buffer was added to each well followed by 50 ul ofthe 
serum sample. To mix the sample the side of the plate was gently tapped. 
• The plate was then covered with the plate cover and incubated for 3 hours at 
room temperature 
• The solution from wells was then aspirated and the liquid discarded. The wells 
were then washed 4 times 
• 100 ul ofbiotinylated anti-IL-ip solution was then pipetted into each with the 
exception ofthe well for the chromogen blanks. Again the side ofthe plate was 
gently tapped to mix the sample. 
• The plate was then covered again with the plate cover and incubated for 1 hour 
at room temperature 
• The solution from wells was again aspirated and the liquid discarded and the 
wells were again washed 4 times 
• 100 ul streptavin-HRP working solution was then added to each well with the 
exception of the chromogen blank, and the plates were then covered and 
incubated for 30 min at room temperature 
• The solution from wells was again aspirated and the liquid discarded and the 
wells were again washed 4 times 
• 100 ul ofstabilized chromogen was then added to each well and the liquid in the 
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wells turned blue 
• The plate was Incubated for a further 30 min at room temperature in the dark 
place 
• 100 ul of stop solution was added to each well and the solution in the wells 
changed from blue to yellow 
• The absorbance was then read at 450 nm (Dynatech MR 5000, Dynatech 
Laboratories Inc., USA) 
IL-6 assay 
• All the reagents were allowed to reach room temperature before use, All liquid 
reagents were gently mixed prior to use. 
• 100 ul of the Standard Diluent Buffer was added to zero wells. Wells reserved 
for chromogen blank were left empty. 
• 100 ul of standards was added to the appropriate microtiter wells for the standard 
curve 
• 50 ul of Standard diluent buffer was added to other wells followed by 50 ul 
serum sample. To mix the sample the side of the plate was gently tapped 
• The plate was then covered plate cover and incubated for 2 hours at 37°C. 
• The solution from wells was then aspirated and the liquid discarded. The wells 
were then washed 4 times. 
• 100 ul ofBiotinylated anti-IL-6 ( Biotin Conjugate ) solution was then pipetted 
into each well except the chromogen blanks. Again the side ofthe plate was 
gently tapped to mix the sample. 
• The plate was then covered again with the plate cover and incubated for 1 hour 
at room temperature. 
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• The solution from wells was again aspirated and the liquid was discarded and the 
wells were again washed 4 times. 
• 100 ul Streptavidin-HRP Working Solution (100 ul solution of Streptavidin-HRP 
and 10 ml ofDiluent) was then added to each well except the chromogen 
blanks, and the plate were then covered and incubated for 30 mins at room 
temperature. 
• The solution from wells was again aspirated and the liquid discarded and the 
wells were again washed 4 times 
• 100 ul of Stabilized Chromogen was then added to each well and the liquid in 
the wells begin to turn blue colour 
• The plate was incubated for a further 30 minutes at room temperature in the dark 
place 
• 100 ul of Stop Solution was added to each well and the solution in the wells 
changed from blue to yellow. 
• The absorbance was then read at 450 nm (Dynatech MR5000, Dynatech 
Laboratories Inc., USA) 
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2.6 Histology 
2.6.1. Macroscopic 
All the animals underwent postmortem examination after each experiment. The 
lung, liver and kidney were examined for the presence of petechiae and 
haemorrhages by macroscopic examination. The macroscopic appearances of these 
organs were recorded and then some of tissue samples were taken for histology. 
2.6.2. Microscopic 
Lung, liver and kidney were preserved in 10% formalin buffer and send to the 
Pathology Department for paraffin sectioning. The samples were all coded with 
random numbers so that the heating group would not be known. A random sample 
of specimens from each group were then identified and these were stained with H & 
E to observe the haemorrhage, tissue damaged. Microscopic examination was 
undertaken with the help ofDr. To of the Department of Anatomic and Cellular 
Pathology. Preliminary analysis would determine if there were obvious differences 
in the specimens particularly in relation to the numbers of macrophages and 
neutrophils. 
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2.7 Data handling and statistical analysis 
Data from the observation sheets (Appendix 1) were entered into Epiinfo (version 
6.04c, CDC Atlanta). Frequency tables for all variables were viewed to check for 
obvious data entry errors. In addition much of the data was double entered and 
verified to check for errors. After errors had been checked some preliminary 
analyses using Epiinfo were undertaken. The PowerLab system measured the data 
output twice per second. This data was then exported to Chart.TXT file using a 600x 
reduction, and then imported to Microsoft Excel format for summary analysis. This 
gave a data reading every 5 minutes of each experiments. Samples of this data are 
shown in Figures 8a and 8b. The data was then exported to SPSS and further more 
detailed analysis undertaken with the help of the Centre for Clinical Trials and 
Epidemiological Research. 
Initial analyses of the data to compare the differences in the cytokine values 
and mortality data within groups and between groups, to observe differences in the 
various physiologic parameters recorded during experiments. 
For descriptive statistics, the data are presented as the mean±SEM. 
Nonparametric analysis using the Annova test was to compare 1) differences within 
each study group and between groups for body weight and cytokine values; 2) data 
of heat stressed group and the control group; and 3) the effects of anaesthesia by 
comparing the C1 control group (without anaesthesia) data with the C2 control 
group (with anaesthesia) and heat stressed group; 4) Mortality rate was assessed 
with Kaplan-Meier survival plots and Cox's regression analysis in the heat stressed 
and MDP groups, p values for all data < 0.05 were accepted as the level of statistical 
significance. 
66 
Chapter 3 Results 
The main laboratory study was conducted during the period September 1998 to 
March 1999. The population of the study was the females Sprague-Dawley rats age 
of 10 days. This population was divided into 3 groups: 50 subjects in control group 
(C1, C2 and C3), 100 subjects in temperature group (T1, T5, T2, T3 and T4) and 80 
subjects in MDP group (Ml, M5, M2 and M3). 3 subjects were eventually excluded 
from the study because of deficiency blood collection. 12 subjects were excluded 
because of suspected contamination of the ketamine solution. The experiments for 
these 15 subjects were repeated. Finally, there were 230 data records available for 
analysis. 
3.1 Group (body weight) characteristics 
Although the animals have the same age and with the same standard food, there was 
some variation in the bodyweight. The body weight of control group, temperature 
group and MDP group are shown in detail in Table 4A, Table 4B and Table 4C. 
Table 4A shows the mean body weight in control group. C1 groups had the 
mean body weight with 22.4 gram，C2 groups had the mean body weight with 21.4 
gram and C3 group had the mean body weight with 21.8 gram. 
Group Case number Age (day) Weight (gram) Std Dev. 
~~C^  To to 2 ^ ^ 
C2 20 10 21.4 3.1 
C3 20 10 21.8 3.0 
Table 4A Body weight (grams) of control group 
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Group Case number Age (day) Weight (gram) Std Dev. 
~T\ 20 To ^T7 ^ 
T5 20 10 21.1 1.6 
T2 20 10 21.2 2.2 
T3 20 10 22.5 2.4 
T4 20 10 21.7 1.8 
Table 4B Body weight (grams) of temperature groups 
The Table 4B shows the mean body weights of the temperature groups. The T1 
group had a mean body weight of 21.7 gram, T5 group a mean body weight of 21.1 
gram, T2 group a mean body weight of21.2 gram, T3 group a mean body weight of 
22.5 gram and T4 group a mean body weight of21.7 gram. 
The Table 4C shows the mean body weight of the MDP groups. Ml group 
had a mean body weight of21.2 gram, M2 group a mean body weight of 20.2 gram, 
M3 group a mean body weight of20.7 gram, and M5 group a mean body weight of 
20.4 gram. 
Group Case number Age (day) Weight (gram) Std Dev. 
' M 1 2 0 1 0 "2i".2 l ' ' 2 
M5 20 10 20.4 1.9 
M2 20 10 20.2 1.5 
M3 20 10 20.7 3.0 
Table 4C Body weight (grams) of MDP groups 
Statistical analysis by One Way ANOVA showed that there was no significance 
68 
Results .. 
different (P=0.093) in body weight between these three groups. However there was a 
significant difference in body weight between the temperature group and MDP 
group (One Way Anova P=0.02 ). Further analyses were undertaken to look at the 
possible influence on body weight on cytokine production (IL-lp and IL-6) and 
mortality (see below). 
3.2 Serum concentration of IL- 6，IL-1 p 
Levels ofIL-ip and R.-6 were measured in pg/mg. Statistical analyses used mean 
levels ofIL-ip, and mean values of the log transformation ofDL-6 (LN JDL6). The 
log transformation ofD^-6 was used because some particular high TL-6 values. 
The mean values of the cytokines IL-lp and LN_JL6 in control groups, 
temperature groups and MDP groups are summarised in Tables 5A, 5B and 5C. 
g~ g2 — — ~ 
™™1^ Va|jd N 5 T6 W " To™~ 
Mean 33.21 41.92 37.45 34.23 
Std Dev 20.14 14.50 17.07 11.44 
IL-6 Valid N 5 10 10 10 
Mean 15.98 15.29 15.06 13.11 
Std Dev 7.72 4.37 6.13 6.22 
LN_IL6 Valid N 5 10 10 10 
Mean 2.59 2.67 2.63 2.45 
Std Dev 0.78 0.39 0.43 0.56 
Table 5A Mean values of DL-ip and TL-6 (pg/mg) in control groups (C1, 
C2, C3) and sham heat-treatment group (T1) 
The C1 group had blood collected by percutaneous cardiac puncture without 
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anaesthesia, the C2 had blood collected by percutaneous cardiac puncture with 
anaesthesia, and the C3 had blood collected by direct cardiac puncture with 
anaesthesia. The T1 group was the sham heat-treatment group that had blood 
collected by direct cardiac puncture with anaesthesia. 
The effects ofwhole body hyperthermia (38�C，39X, 40°C and 41�C) on 
cytokines production are shown in Table 5B. However the data for temperature 
Group 4 (41�C) were not included in the statistical analysis for the reasons 
previously discussed. 
T1(34) T5(38) T2(39) T3(40) T4(41) 
" " • ^ ^ ^ Valid N To t6 W Tb 10 
Mean 34.23 36.71 31.36 35.92 37.63 
Std Dev 11.44 11.80 10.24 13.19 11.74 
IL-6 Valid N 10 10 10 10 10 
Mean 13.11 16.70 39.54 17.73 19.58 
Std Dev 6.22 7.02 23.29 2.74 6.44 
LN_IL6 Valid N 10 10 10 10 10 
Mean 2.45 2.70 3.50 2.86 2.92 
Std Dev 0.56 0.55 0.63 0.16 0.35 
Table 5B Mean values of BL-ip and IL-6 (pg/mg) in temperature groups 
The effects ofMDP (25 nmol/animal EP) on cytokine production are shown in the 
Table 5C. 
Oneway Anova showed that there was no significant differences between the 
mean IL-ip and LN_EL6 in the four control groups (Table 6). 
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M1(34) M5(38) M2(39) M3(40) 
"““iUTp Valid N Tb To To To~~ 
Mean 34.83 38.05 54.06 45.52 
Std Dev 13.73 15.65 18.70 12.50 
IL-6 Valid N 10 10 10 10 
Mean 15.64 41.39 120.17 74.78 
Std Dev 13.47 35.60 197.83 122.23 
LN_IL6 Valid N 10 10 10 10 
Mean 2.36 3.35 3.09 3.51 
Std Dev 1.02 0.99 2.10 1.31 
Table 5C Mean values ofIL- ip and JL-6 (pgAng) in the temperature 
groups pre-treated with muramyl dipeptide (MDP) 
joaaooMXKw^aKKMMKM*K*nxMM*wjjMM**w*wj*POJ*w*w*wjxMJJuuuuuuuiauum>jumjuujwpjmjijumjuuuuij j i jwjj j i j j j j jumjjuumjjuijuMjupjumjuu>jmjuoqt 
Mean Std. deviation F P 
IL-ip Cl 33.21 " ^ ^ 
0.552 0.651 
C2 41.92 14.50 
C3 37.45 17.07 
T1 34.23 11.44 
LN_IL6 C1 2.59 0.78 
0.337 0.799 
C2 2.67 0.39 
C3 2.63 0.43 
T1 2.45 0.56 
Table 6 One way anova of DL-ip and LNJCL6 values (pg/mg) in control 
groups (C1, C2, C3) and sham heat-treatment group (T1) 
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These results suggest that anaesthesia (ketamine 55mg/kg, I.P.), direct cardiac 
puncture and sham-heat treatment did not elevate the levels ofIL-ip and IL-6. 
Univariate analysis of variance was used to assess the between subject 
effects of group (Temperature group versus MDP group) and the temperature (34�C, 
38°C, 39�C and 40�C) with the 34�C group being the sham heat-treated group. 
These results are shown in Tables 7A and 7B. 
WVWWWWWVWWWWWWWmWMVWVWMAAAfVWWVWWWVWVWVVWVVWWWVVWWVWWVWWVmVtMMMAAMWtfWmWMWHVVVVVVWVWVVVWVVVVVVWWVWWVtAmWM*k 
df F p 
Group i 7.335~~~0.008 
(Temperature versus MDP) 
Temperature 3 1.309 0.278 
(34�C,38�C,39�Cand 40�C) 
Table 7A Between subject effects of dependent variable D^-ip 
* * w * * " _ " * * * * * * * * = " * * * * * * * * * * w * * * * * * * * * * * * * * * * * * * * * * * * * * * * w * * * * * * * * * * * * J u u u u u u u w u u u u u m w j u u u M J u m j u u m j m j m j u w u u w w j M M j m j u u u u u u u w J u u m j 
df F p 
Group i 0.661""""0.419 
(Temperature versus MDP) 
Temperature 3 2.738 0.049 
(34�C，38�C, 39�C and 40�C) 
Table 7B Between subject effects of dependent variable LN_IL6 
From these two tables, it is noted that LL-ip production is influenced by the 
administration ofMDP but not by the level of temperature, whereas the JL-6 
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production is influenced by the level of temperature but not by the administration of 
MDP. These results of the EL-ip in the temperature groups and the MDP groups are 
shown graphically in Figure 10 and the results for IL-6 in Figure 11. 
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Figure 10 Between subject effects of dependent variable EL-1 
For n^-ip，values in the temperature groups increased at 38°C, reached the 
maximum level (peak) at 39�C，and then decreased at 40�C. Values ofEL-ip in 
MDP group have the maximum level at 38�C, decreased at 39°C, and then increased 
at 40�C OFigure 10). 
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Figure 11 Between subject effects of dependent variable LN_IL6 
For IL-6, values in temperature group increased at 38°C，reached the maximum level 
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(peak) at 39°C, and then decreased at 40°C. Values for IL-6 in the MDP groups 
were at a maximum level at 38°C, decreased at 39°C, and then increased at 40°C 
(Figure 11). 
Effect of Body weight on cytokine production 
In view of the concern that the apparent lower body weights in the MDP group 
might affect the results the Univariate analysis of variance repeated with the 
inclusion ofbodyweight in the model. This showed no significant effect of 
bodyweight on either IL-lp or JL-6 (Table 8A and 8B). 
3 ? ~ F " p 
Body weight 1 M 0.975 
Group 1 6.682 0.012 
(Temperature versus MDP) 
Temperature 3 1.280 0.288 
(34oC,38�C,39�C and 40°C) 
4J*AA»«M>««^M***ji>r_|__i___^_M__»_M^»»_Bj«i_^»_^_^^j^«^«M««M««««^««»_«fc_ '^^ ^M_»«_»__»»»__'_»_，《__^_，__^^，^_^fl，f^^nnnwfiflBRn.n.H.BB.fmpflfifliiiH,n_frnHnnHHffflBnjCT 
Table 8A Between subject effects of dependent variable IL-ip with the 
inclusion of bodyweight in the model 
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5 ? ~ F p 
Body weight 1 ^ 0.879 
Group 1 0.544 0.463 
(Temperature versus MDP) 
Temperature 3 2.653 0.055 
(34�C,38�C,39�C and 40�C) 
Table 8B Between subject effects of dependent variable LN_EL6 with the 
inclusion of bodyweight in the model 
Analysis of cytokine results between individual groups using t-tests 
To look at the results of the cytokines levels within the various temperature and 
MDP groups in greater detail and series of t-tests were performed between the 
individual groups. These results are shown in Tables 9A and 9B. 
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• jumjmjmjuuuuuuouuuuwwwuuuuwwuwuuuuouuuwauui jumjuuouououuoumJum*JuuuuuuuuuM«*mM»*«»«**»«*»«**»***»****»***w***x***w*WJWM**»****««******^^ 
df F P 
(2-tailed) 
T1 (34°C) versus T5 (38°C) 5^™~0^“™0.639 
Tl(34�C)versusT2(39�C) 18 0.161 0.561 
T1 (34�C) versus T3 (40°C) 18 0.024 0.763 
T1 (34^C)versusMl (34°C) 18 0.201 0.917 
T5 (38�C) versus M5 (38�C) 18 1.978 0.832 
T2 (39°C) versus M2 (39°C) 18 4.130 0.003 
T3 (40^C) versus M3 (40°C) 18 0.017 0.112 
Ml (340C) versus M5 (38�C) 18 0.380 0.631 
Ml (34�C) versus M2 (39�C) 18 1.394 0.017 
Ml (34�C) versus M3 (40�C) 18 0.151 0.085 
Table 9A T-tests for IL-ip 
These results show that temperature had no significant effect on the DL-lp level in 
the absence ofMDP. However pre-treatment with MDP significantly increased the 
IL-lp level in the M2 Group (39�C). For EL-6 there was a significant increase in IL-
6 with heating for the temperature groups without MDP [except for Group T5 
(38^C)] and for MDP pre-treatment groups [except for Group M2 (39°C)]. 
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5 ? “ F P 
(2-tailed) 
—TrG25(5ySir^s�5r"(^i�y lS………57593••…o'3^ » 
T1 (34°C)versus T2 (39°C) 18 1.179 0.001 
T1 (34°C) versus T3 (40°C) 18 3.703 0.039 
Tl (34�C)versusMl(34�C) 18 2.873 0.798 
T5 (38°C) versus M5 (38�C) 18 2.674 0.089 
T2 (39°C) versus M2 (39°C) 18 11.662 0.558 
T3 (40�C) versus M3 (40�C) 18 7.985 0.138 
Ml (34�C) versus M5 (38°C) 18 0.001 0.041 
Ml (34°C) versus M2 (39°C) 18 5.995 0.333 
Ml (34�C) versus M3 (40�C) 18 0.206 0.042 
Table 9B T-tests for LN_IL6 
3.3 Temperature 
In the control group, the animals were kept with mother rat for two hours 
experiments. The temperatures of the control groups were not measured while the 
animals were with their mothers. The rectal and skin temperatures were recorded by 
the PowerLab system during experiments. 
The changes of skin and rectal temperature in different groups were shown in 
Figures 12a and 12b. The ambient temperature of perspex box was between 25-
30°C. The baseline temperatures of the animals at the start of the experiment were 
between 32-34�C. The time from baseline temperature to desired temperature was 
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about 15-20 min and this temperature was kept for about 65 min. The temperature 
then fell slowly to 34°C over about 40 min. 
The pattern of temperature ofheat plate, skin, rectal, ambient and power 
were similar between the temperature group and MDP group and no obvious 
changes. 
Temperature group 
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Figure 12a Summary results of temperature data recorded with the 
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Figure 12b Summary results of temperature data recorded with the 
PowerLab system for MDP Group 
3.4 Mortality rate 
There were no deaths of animals during 2 hours experiments in three control groups. 
The duration of survival of animals is summarised in Table 10. 
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Total n Number Number Mean Survival Percent Survival 
Died Survived time in minutes (%) 
(SE) 
"T1+M1……20 i' 'f9 l'i'6(4) 95 
(34�C) 
T5+M5 20 1 19 115 (5) 95 
(38�C) 
T2+M2 20 8 12 97 (8) 60 
(39�C) 
T3+M3 20 17 3 58(7) 15 
(40�C) 
Table 10 Survival analysis for the four temperature: Tl+Ml (34°C), 
T5+M5 (38°C), T2+M2 (39�C) and T3+M3 (40�C) 
Table 10 shows the number of deaths increased with temperature from 1 in group T1 
(34�C) to 17 in group T3 (40�C) group. The percentage survival {Cummulative 
Survived) decreased from 95% in group T1 (34�C) to 15% in group T3 (40�C). The 
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Figure 13 Kaplan-Meier survival plot for four temperature groups: Tl+Ml 
(34�C)，T5+M5 (38�C)，T2+M2 (39�C) and T3+M3 (40�C) 
As would be expected the Kaplan-Meier survival analysis showed a statistical 
significance difference (Statistic 47.81, df3, p=0.000) in survival duration between 
the four groups Tl+Ml (34�C), T5+M5 (38�C), T2+M2 (39�C) and T3+M3 (40°C). 
A second Kaplan Meier survival analysis was done to investigate the 
differences in survival duration of the MDP and temperature groups. The mean 
survival time in temperature group (n=40) was 104 minutes (95% confidence 
interval 94-113, standard error 5) and in the MDP group (n=40) was 88 minutes 
(95% confidence interval 75-101，standard error 7). The test statistics for equality of 
survival distributions showed a borderline statistical significant result (Statistic 3.24, 
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df 1, p=0.072) Thus although these results do not show that administration ofMDP 
increases mortality rate there is a trend to suggest that there might be an effect. 
Kaplan-Meier survival plot for these data are shown in Figure 14. 
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Figure 14 Kaplan-Meier survival plot for two groups with and without 
muramyl dipeptide (MDP) pre-treatment 
A Cox regression analysis was also performed to look at the combined effect of 
group (M or T), and Temperature (34°C, 38°C, 39°C and 40°C) on survival 
duration. There was a statistical significance difference (Cox Regression p=0.016) 
for the effect of group (M or T) which is shown in Table 11. This suggests that 
hyperthermia combined with infection can increase the mortality rate in the neonatal 
rat. The Cox regression analysis was then repeated with inclusion ofbody weight in 
the model. The showed no significant effect of weight (Cox Regression P=0.356).on 
the results which are shown in Table 12. 
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Variable s E . W ^ df Sig 
Group effect~~0.408~~~5.761 1 0.016 
(M orT) 
Temperature 27.189 3 .0000 
effect 
Temp 34°C 1.039 12.103 1 0.005 
Temp38�C 1.039 12.261 1 0.005 
Temp 39�C 0.441 9.700 1 0.002 
Table 11 Cox regression analysis to assess the effect of Group (with (M) or 
without (T) muramyl dipeptide) and temperature (34°C, 38°C or 
39�C> 
*^w<<">*<**< *^<<">***<***<< *^<**"*M*>*"<fyHTTP*MinnP*^ rr"*^ ******"<<*<**""***<*<*wMW<Y*fiwp>wi>M<>Mw>M>w*<<t^ wMMWMWYWww^w^w<>w^<*wwwwwwwy^wyw^www<M*<>M^^ww^^wywYy^ 
Variable S.E. Wald df Sig 
—^^ i^i^ b'iSSS '6".'45i'……i^ ^ 1 tT08i 
(M or T) 
Temperature 28.185 3 0.0000 
effect 
Temp 34°C 1.038 12.197 1 0.0005 
Temp 38°C 1.039 12.261 1 0.0005 
Temp 39°C 0.441 9.701 1 0.0018 
Weight 0.110 0.853 1 0.356 
Table 12 Cox regression analysis to assess the effect of Group (with (M) or 
without (T) muramyl dipeptide) and temperature ( 3 4 � C � 3 8 � C or 
39°C) with the inclusion of weight in the model 
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3.5 Cardio-respiratory parameters 
It was not possible to record cardiac and respiratory rate as suitable transducers 
could not be identified for use with the PowerLab system. Respiratory rate was 
recorded visually every 15 minutes interval by observing the movement of the 
abdominal wall. The PowerLab system was able to record environmental oxygen 
and carbon dioxide within the perspex box. However these parameters were not 
changed and are therefore not analysed or reported. However if in future 
experiments it was required to manipulate these parameters these would be readily 
measured with the PowerLab system. 
Respiratory rate changes associated with thermal condition for the 
temperature group and MDP group are showed in the Figure 15a and 15b. This 
shows the respiratory rate at baseline (T1 = 34°C) was around 150/min (93-
150/min), and that the respiratory rates in the heated groups (T5=38°C, T2=39^C, 
T3=40�C and T4=41°C) tended to be lower by 10-20 breaths/min. In the animals 
that died the respiratory rate dropped down below 90 breaths/min approximately 15 
minutes before death (89-30/min). The colour of the skin and mucosa of the animals 
turned pale, and then dark before the breathing stopped. 
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Changes of the respiratory rates in TEM P groups 
180 n 
16� "^"^ """*"^ "*"""""""""""""*""""^ """"""^ ~~ ^*-"^""--^-^#>-_^ • - ^ T 2 
； ： ^ ： ： ^ ^ ^ ^ ^ ^ ^ ^ ^ a 
! i � � ^ ^ ! ! ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ / ^ ^ 
H v ^ ^ ^ 




0 15 30 45 60 75 90 105 120 
Time (mins) 
Figure 15A Changes in mean respiration rate in Temperature Group 
Changes of the respiratory rate in MDP group 
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Figure 15B Changes in mean respiration rate in MDP Group 
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3.6 Macroscopic findings at postmortem 
Status ofbleeding were classified into four degrees: O=no bleeding, !=occasional 
bleeding, 2=moderate bleeding and 3=severe bleeding. The macroscopic findings of 
bleeding into the lungs, livers or kidneys of the animals in all the groups are shown 
in Tables 13a-c. No petechiae or bleeding were seen on the surface of the lung, 
kidney, and liver in the three control groups Cl，C2 and C3. 
Bleeding appear on the surface of liver and kidney increased with increasing 
temperature shown in Tables. In T5 (38°C) group, 2/10 of animal have bleeding in 
liver and kidney; T2 (39°C) group, 10/10 of animals had bleeding in liver and 9/10 
in kidney; T3 (40°C) group, 10/10 of animals had bleeding in liver and kidney; T4 
group (41°C), 100% (10/10) of animals had bleeding in both liver and kidney. Only 
occasional animals had evidence ofbleeding on the surface of lung. 
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Group O=none 1=occasional 2=moderate 3=severe 
bleeding bleeding bleeding 
Control groups 
C1 (n=10) 5 0 0 0 
C2(n=20) 10 0 0 0 
C3(n=20) 10 0 0 0 
Temperature groups 
T1(34�C)Sham 10 0 0 0 
heat-treatment 
T5 (38�C) 9 1 0 0 
T2(39�C) 10 0 0 0 
T3 (40�C) 9 0 1 0 
T4(41�C) 10 0 0 0 
Muramyl dipeptide treated group 
M1(34�C) 9 2 0 0 
M5 (38°C) 10 0 0 0 
M2(39�C) 10 0 0 0 
M3(40�C) 10 0 0 0 
Table 13a Evidence of macroscopic bleeding into lungs of neonatal rats 
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Group O=none 1=occasional 2=moderate 3=severe 
bleeding bleeding bleeding 
Control groups 
C1 (n=10) 5 0 0 0 
C2(n=20) 10 0 0 0 
C3 (n=20) 9 0 1 0 
Temperature groups 
T1(34�C)Sham 10 0 0 0 
heat-treatment 
T5 ( 3 8 � Q 5 4 1 0 
T2 (39�C) 0 2 6 2 
T3 (40�C) 0 0 2 8 
T4(41�C) 0 0 3 7 
Muramyl dipeptide treated group 
M1(34�C) 9 1 1 0 
M5(38�C) 10 0 0 0 
M2 (39�C) 2 1 4 3 
M3 (40�C) 0 1 0 9 
Table 13b Evidence of macroscopic bleeding into liver of neonatal rats 
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Group O=none 1=occasional 2=moderate 3=severe 
bleeding bleeding bleeding 
Control groups 
C1(n=10) 5 0 0 0 
C2 (n=20) 10 0 0 0 
C3 (n=20) 9 1 0 0 
Temperature groups 
T1(34�C)Sham 10 0 0 0 
heat-treatment 
T5 (38�C) 6 3 1 0 
T2 (39�C) 1 7 2 0 
T3 (40�C) 0 5 5 0 
T4(41�C) 0 5 4 1 
Muramyl dipeptide treated group 
M1(34�C) 9 2 0 0 
M5(38�C) 10 0 0 0 
M2 (39�C) 5 1 2 2 
M3 (40�C) 1 5 3 1 
Table 13c Evidence of macroscopic bleeding into kidneys of neonatal rats 
Chi-square test shown that there were significance differences between the control 
group, temperature group and MDP group with regards to the amount ofbleeding in 





All animals that died or were sacrificed at the end of the studies had a postmortem 
examination performed and tissue was taken from the lungs, liver and kidney for 
histopathological examination. These tissues were stained with hematoxylin and 
eosin (H&E). 
An initial pilot examination of the tissues was carried out. One sample from 
each of the groups was viewed unblinded. Examples of these histopathological 
features are shown in Figures 16-19. In this pilot examination, it was not possible to 
demonstrate consistent abnormal changes due to the effects of hyperthermia and 
MDP administration, although indication of increased abnormalities were noted in 
the groups placed at moderately higher temperatures. 
1. Liver: In the heat-treated animals (T2 and M2 group), hepatic congestion, 
activation ofKupffer cells and fatty change of the hepatocytes was noted. 
Increased apoptosis of the hepatocytes was also seen. 
2. Lung: There was no clear evidence of congestion or haemorrhage in the samples. 
In the heat treated animal (T2 and M2 group), the alveolar septa appeared 
expanded with increased monounclear cell infiltration. However evidence of 
acute pulmonary injury was not apparent. 
3. Kidneys: Microscopic evaluation of the kidney did not reveal any significant 
glomerular or tubular interstitial injury on light microscopy in the pilot samples. 
This initial examination was not blinded. Therefore to determine whether these 
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Figure 16 Neonatal rat lung tissue stained with H&E and viewed under low 
power magnification (6.3x10). The top picture shows normal lung 
tissue and lower picture shows abnormal tissue with thickened alveolar septa and inc ased inflammatory cells. 
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Figure 17 Neonatal rat lung tissue stained with H&E and viewed under 
magnification of 16x10. Top picture shows normal tissue and 
lower picture shows abnormal tissue with thickened alveolar 
septa and interstitial mononuclear cells. 
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Figure 18 Neonatal rat liver tissue stained with H&E and viewed under 
high power magnification (40x10). The top picture shows normal 
tissue and lower picture shows evidence of fatty change and 
cellular degeneration. 94 
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Figure 19 Neonatal rat liver tissue stained with H&E and viewed under 
magnification of 16x10. The top picture shows normal portal 
triad and lower picture shows abnormal tissue with increased 
Kupffer cells and mild fatty change. 
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Chapter 4 Discussion 
4.1 study Model 
4.11 Core temperature ofnewborn rat 
The rectal temperature of newborn rats in the nest varies between 32°C and 39°C, 
depending on environmental temperature and the presence of the dam (Malcolm & 
Henderson-Smart, 1996). During our pilot studies, it was found the temperature of 
neonatal rat was not 37°C. We therefore measured the temperature in 12 neonatal 
rats aged 10-14 days, and revealed the temperature of rat pup was between 30 to 
34°C depending on the age. It was decided to use a baseline temperature of 34°C for 
the sham heat-treatment group (see section 2.3.1). Schmidt and colleagues measured 
the core temperature of rat pup litters aged 5-8 days, 30 to 60 min after the mother 
spontaneously left the nest. These results showed that the core temperature of these 
animals was low and variable (32.2°C to 35.4°C) during the first few hours after 
lights-on, but the core temperature was uniformly high and much less variable (35.5 
� t o 36.5°C) around the time oflights-off (Schmidt et al., 1986). In our study, we did 
the experiments during daytime, so the temperature variable between lights-on and 
lights-offwas not considered. However this would suggest that a baseline 
temperature of34°C used in our study was reasonable during daytime. Another 
investigator measured the rectal temperature of newborn rat (n=117, 1-15 days), and 
indicated that there is a positive correlation between postnatal age and temperature, 
but the mean was 33.5^C (Malcolm & Henderson-Smart, 1996). In our study rectal 
temperatures were measured using a probe inserted 3mm into the rectum. In 
experiments measuring core temperature the thermocouples were inserted 5-10 mm. 
Discussion 
The probe used in our experiment was tapered. This meant that it was easy to insert 
that probe to 3 mm but not to a greater distance due to a wider calibre if the probe 
after this distance it was not possible to insert the probe deeper. Whether failure to 
insert the temperature probe to a deeper level would underestimate the actual core 
temperature to which the animal is heated is not clear. However the corresponding 
skin temperatures measured were within a similar range to the rectal temperatures. 
Even if the core temperature were being underestimated this would not influence the 
overall results as the same procedure was used in all experiments and it is the 
relative differences in temperature which is important rather than the absolute 
temperature. 
4.12 Temperature calibration 
During the pilot study, the problem of calibration of the equipment was identified 
when readings were taken together with the temperature sensors attached to the 
Temperature Controller and the Bioprobe system to the PowerLab. From the result 
of pilot study, it appeared that the animals were being heated to higher real 
temperature to that which was being recorded. The difference in temperature was 1-
2°C and was non-linear (Table 2). The error in calibration could have come from 
two sources: the temperature sensor of the Bioprobe and amplifier or the 
temperature output reading recorded on the Temperature Controller. Various 
attempts were made to calibrate and standardise the temperature reading. Initially 
the temperature reading measured by the Temperature Controller was calibrated 
against a Temperature Standard made by the TSU of the Chinese University ofHong 
Kong. However as the temperature recorded by the Bioprobe sensors was closer to 
readings measured with a mercury thermometer and a commercially obtained digital 
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thermometer it was considered that these temperatures should be used to standardise 
the Temperature Controller. There was also some minor differences (<0.5°C) in the 
temperature readings obtained from three different Bioprobe sensors. Details of the 
basic accuracy of the Bioprobe sensors is shown in the Appendix but within a range 
of -20 to 350°C the accuracy is 士（0.5o/o of reading + 2°C). These specifications are 
stated to apply for 1 year after purchase. After the second recalibration the 
temperature readings of the two different temperature sensors (Bioprobe and 
Temperature Controller) were compared before each experiment. This suggested 
that the Temperature Controller was under-reading by 0.5-l°C for a number of the 
experiments. However frequent recalibrations were not possible and it was decided 
that the relative temperatures were more important than the absolute temperatures. 
As a result of these difficulties the temperatures groups (39�C, 40�C and 
41°C) were found to associated with a higher mortality than had been noted in the 
pilot experiment. This appeared to be related to the fact that before recalibration the 
temperature controller had been over-reading and after recalibration was slightly 
under-reading. These difficulties mean that when interpreting the temperature 
measurements in this study, it will important that they are viewed as relative rather 
than as absolute temperatures. 
4.13 Respiratory and pulse rate measurements 
Respiratory and pulse rate can be measure with suitable transducers in humans and 
larger animals and recorded by PowerLab system. In this neonatal rat model, it had 
been hoped to measure respiratory rate and pulse rate but suitable attachments and 
transducers could not be found for the neonatal rat (see section 2.2.1). Failure to 
measure these parameters will not have affected the cytokine results although they 
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would have given additional information on the patho-physiological processes of 
hyperthermia in this small animal model. 
4.14 Measurement ofsleep state 
Sleep is defined as unconsciousness from which the person can be aroused by 
sensory or other stimuli. There are two different types of sleep, one is slow wave 
sleep (SWS) and another is rapid eye movement (REM) sleep. In the slow wave 
sleep, the brain waves are very slow. Most sleep during each night is of the slow 
wave variety. This is the deep, restful type of sleep. In the REM sleep state, the eyes 
undergo rapid movements despite the fact that the person is still asleep, the brain is 
quite active. This type of sleep is not so restful, and it is usually associated with 
vivid dreaming (Guyton AC. & Hall JE., 1997). 
Sleep state is measured for a number of different research purposes. Galland 
and Bolton measured the sleep state in piglet with EEG and EOG to investigated the 
sleep state before, during and after a period of sustained hyperthermia (Galland et 
cd., 1993). In a subsequent study Galland and colleagues (1994) monitored sleep 
state using the EEG in piglets to determine the amount of time spent awake, in 
NREM and in REM sleep for three successive 60 min periods to determine the 
degree of asphyxiation and/or hyperthermia encountered. Krueger and colleagues 
used New Zealand rabbits to record sleep state with electroencephalogram and to 
test the effects ofMDP on sleep (Krueger etal., 1982). Although we had initially 
considered including arousal and sleep state as outcome measures in our study, the 
requirement for anaesthesia made these parameters less important to measure. 
4.2 Animal age and weight 
Important factors that may affect the results in this study are the animals' age and 
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body weight. Before the start of the main experiments, there was a concern as to 
what was the optimal age of animal to study. This is an important decision may 
influence the feasibility of the study and the final results. Ideally we had wished to 
select the age of the neonatal rat at which it would be developmentally equivalent to 
a three-month old infant. However little data could be located on the normal 
development of thermoregulatory processes in neonatal rat pups. Although 
thermoregulatory mechanisms and development in humans and rats probably differ 
significantly, it would have been ideal to determine if a certain age of neonatal rat 
would correspond most closely in terms of thermoregulatory development to a three-
month old infant. Advice was sought on this aspect and it was suggested that this 
decision depends on the parameter being considered but from a thermoregulatory 
viewpoint a 6-7 days old rat might be a better choice. However an important part of 
the experiment was to collect blood from the neonatal rat for cytokine assay. The 
blood collection process was more difficult in the very young rats and the blood 
volume required for the cytokine assays needed to be at least 1 ml. It was found that 
it was only possible to get adequate blood in rat pups aged 10 days or over. If 
neonatal rats aged 6-7 days were used it would not have been possible to obtain 
sufficient volume ofblood for cytokine assay. At 10 days ofage sufficient blood 
could be collected to measure at least two cytokines and possibly three cytokines 
(IL-ip, IL-6 and possibly TNF-a). 
The body weight ofMDP group was lower than temperature group. This 
related to the fact that the original random timetable of experiments could not be 
followed due to late arrival of the MDP. It was considered possible that a difference 
in body weight would influence cytokine production and mortality rate. However an 
analysis to look for an effect of weight on cytokine production showed no significant 
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effect on mortality (P=0.356) or IL-6 (P=0.879) and IL-lp (P=0.975) production. 
4.3 Cytokines response to heating 
Cytokines, can be defined as soluble mediators that modulate the process of natural 
and specific immunity (Bertagnolli MM, 1993). They are protein or glycoprotein 
factors secreted by cells ofboth monocytoid and lymphoid lineages (Bona & 
Bonilla, 1996), and fimction as up- and down-regulators of immunological, 
inflammatory, and reparative host response to injury (Oppenheim et al., 1994). 
There are four types of cytokines: Interferons (IFN): e.g. IFN-alpha, IFN-
beta and IFN-gamma; Interleukins (IL): eg. JL-l to EL-15; Colony-stimulating 
factors (CSF): e.g. Granulocyte-CSF, Macrophage-CSF and Granulocyte-
Macrophage-CSF; Tumour Necrosis Factor (TNP): e.g. TNF-alpha and TNF-beta 
(Male & Roitt, 1996). Some factors can cause cytokines release including: infection, 
hyperthermia, stress, smoking and others. Inflammatory cytokines such as IL-1, IL-6 
and TNF are usually measured in experiments to assess cytokine response to 
infection or heating. In our present study, we initial planed to measure IL-ip, IL-6 
and TNF-a to investigate the cytokine response to effect ofhyperthermia and the 
effect ofMDP in neonatal rat. However in experiments involving rats and 
hyperthermia no significant increase in TNF levels in any sample was detected 
(Haveman et al., 1996). This finding, together with limited amounts ofblood 
samples, resulted in only IL-ip and IL-6 being measured in this study. 
Response to heat treatment including the effects on endothelial cells leading 
to vascular leakage, oedema and infiltration with neutrophils, strongly resemble 
those from the inflammation response and also include the release of cytokines. 
Furthermore, the direct cell killing effect ofhyperthermia, notably at temperatures 
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above 42 °C has been implicated to play a role. Cytokines form a complicated 
network and there is a feedback system exists between cytokine production and 
fever generation (Kappel & Diamant, 1991). A number of studies have been done to 
detect the response to heating both in humans and animals. 
In a human study, Bouchama and co-workers (1991) found that the TNF-a 
and IL-la are elevated in the plasma ofheatstroke patients. They found an elevation 
ofKv-6, n,- ip and ENP-y in 100 percent, 39 percent and 50 percent respectively of 
heatstroke patients (Bouchama et al., 1993). There has been interest in whole body 
hyperthermia for the treatment of neoplastic disease as an adjunct to cytotoxic 
therapy. Hyperthermia can enhance neoplastic cell death by various genotoxic 
therapies, but it has variable effects on hematopoietic tissue (Robins et aL, 1995). In 
1993, D'Oleire studied cytokine induction by 41.8°C whole body hyperthermia in 9 
cancer patients, and revealed that G-CSF, EL-ip and TNF-a was induced in the 
plasma of all patients after 3 to 6 hours whole body hyperthermia (d'Oleire & 
Robins, 1993). Following above preliminary study, Robins and Kutz (1995) 
demonstrated that whole body hyperthermia (41.8�C) can induced elevating plasma 
levels of G-GSF, interleukin-lp, interleukin-6, interleukin-8, interleukin-10 and 
tumor necrosis factor-a within hours of whole body hyperthermia (Robins et al, 
1995). 
Externally induced hyperthermia may lead to enhanced production of 
cytokines in animals. Neville and Sauder (1988) showed that in the skin of mice 
treated by 41-42 °C whole body hyperthermia, the level ofIL-l was elevated 16 
hours after WBH OSFeville & Sauder, 1988). Goto and his partner (1984) studied 
casein induced inflammation in the peritoneum of mice. A peak was observed at 4 
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hours after injection of casein attributed to IL-1 like lymphocyte stimulating factor. 
This correlated with the infiltration by polymorphonuclear lymphocytes (Goto & 
Nakamura, 1984). Haveman and Geerdink (1996) have investigated cytokine levels 
in the serum of rats after both externally induced WBH and localized hyperthermia. 
Results showed that levels ofIL-1 and IL-6 in blood were enhanced after 1 hour 
treatment of 41.5°C whole body hyperthermia. IL-1 reached a peak level after about 
15 mins of reaching a WBH temperature of 41.5 °C. IL-6 levels were not enhanced 
during WBH but 1 hour after WBH a clear peak was observed. No increased levels 
ofH^-6 or TNF were detected after localized hyperthermia treatment for 30 min at 
43 or 44 °C (Haveman et al., 1996). 
The results of our study indicate that whole body hyperthermia (38°C, 39°C, 
40°C and 41 °C) can increase the level ofIL-6 after 1 hour ofhyperthermia 
treatment as compared to the sham heat treated group. However WBH did not 
significantly increase the level ofIL-ip. Haveman's study indicated the serum levels 
ofIL-1 quickly rise to a maximum already during WBH (41.5�C), and remained 
high for 1 hour after WBH, then quickly return to control levels (Haveman et al., 
1996). High levels ofIL-ip may be underestimated by missing the peak in some 
patients due to the variable time between the onset of symptoms ofheatstroke and 
the collection ofblood samples as the increased IL-ip will bind to certain plasma 
proteins (Dinarello & Krueger, 1986). To detect these peaks it will be necessary to 
undertake frequent blood sampling. However, in our study it would have been 
impossible to take frequent samples from a 10 days neonatal rat. 
Evaluation ofIL-6 has also been observed in some clinical studies. Serum 
levels ofEL-6 correlate with the amount of fever present in patients with burn 
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injuries (Nijsten et al., 1987) and IL-6 levels have also been reported to be elevated 
in patients undergoing renal rejection (Van Oers & Van der Heyden, 1988). These 
results are similar to our findings with regards to IL-6. 
Anaesthesia (ketamine 55mg/kg) had no effect on the cytokine IL-ip and IL-
6 production in our study. The possible effect of anaesthesia on cytokine production 
was considered in our study because Haveman's study indicated the anaesthesia 
(diethylether) with sham WBH did not lead to enhanced IL-6 levels but induced a 
small significant peak level of approximately 131 U/ml IL-1 six hours after 
treatment (Haveman et al., 1996). In our study anaesthesia did not appear to 
influence the production ofIL-ip and IL-6 but the duration of our experiments may 
be a factor. We measured JL-l at two hours and not after 6 hours. Another 
explanation could be the direct effect of anaesthesia agents on cytokine production. 
In our study ketamine (I.P. 55mgy'kg) was used as the anaesthesic agents, whereas 
diethylether was used in Haveman's study. There are also a other methodological 
differences between the two studies that may explain a lack of an effect in our study. 
4.4 Cytokine response to MDP 
N-acetyl-muramyl-L-alanyl-D-isoglutamine (MDP) is a synthetic muramyl peptides, 
known as component ofbacterial cell wall peptidoglycan. It has been recognised that 
MDP is both pyrogenic and somnogenic (Krueger et al., 1982). Furthermore, it may 
act as a bactericidal agent in at least two ways. It may act on macrophages so that 
they produce augmented amounts of oxygen radicals (Pabst & Johnston, Jr., 1980; 
Kaku & Yagawa, 1983) and it also enhances production ofInterleukin-1 by 
macrophages (Leclerc & Chedid, 1982). Supernates from activated macrophages can 
induce excess slow-wave sleep (SWS) (Pappenheimer, 1983). 
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Pyrogenic effects ofMDP have been shown by several investigators. Meltzer 
found that the MDP (given subcutaneously lml/kg) induced a non-dose-related 
increase in body temperature in adult rats (Meltzer et al., 1989). Muramyl dipeptide 
induced fever in cats (Amini-Sereshki-Kormi, 1996). Intraventricular injection of a 
somnogenic dose ofMDP can induce fever in rabbits without increasing plasma or 
cerebrospinal fluid levels ofIL-1 (endogenous pyrogen) (Riveau etal., 1980). 
In our study, the effects ofMDP on mortality and cytokine production were 
assessed in neonatal rats. Data on sleep state and pyrexial response were not 
collected. Excess sleep induced by MDP is easily disturbed by procedures such as 
the insertion of rectal probes for measurement of temperature or even by the 
presence ofhuman activity in an open laboratory. It is unlikely that the somnogenic 
effects ofMDP would be noted without recording EEGs in animals maintained in an 
environment free from disturbances (Krueger et al., 1982). 
MDP was given intraperitoneal in a dose of 25 nmol /animal and this led to a 
significant increase in the level ofIL-ip in the neonatal rat (p=0.008). MDP had no 
significant effect on the IL-6 level (p=0.42). (AbehsiraAmar & Damais, 
1985)Studies have noted that MDP induces the production ofIL-1. Both synthetic 
and naturally occurring MDP exert their biological effects, in part by inducing IL-1 
(Dinarello & Krueger, 1986). MDP enhances the production ofthe cytokine IL-1 in 
vivo and in vitro (Cady et al., 1989). 
MDP did not increase the level ofEL-6 in our study. Suzuki et. al. have 
reported MDP stimulated the production ofEL-l, IL-6, TNF and IL-1 receptor 
antagonist. Their kinetics study indicated that IL-1, TNF and IL-1 receptor 
antagonist were induced after 4 hours stimulation but EL-6 was produced at a later 
phase (Suzuki & Torii, 1994), Time course differences may possibly explain why 
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MDP had no effect on IL-6 production in our study. 
4.5 Hyperthermia, MDP and mortality 
Hyperthermia is a state of thermoregulatory failure subsequent to the inability to 
dissipate a heat load at a sufficient rate (e.g. heat stroke), or excessive heat 
production with a normal rate ofheat loss (e.g. malignant hyperthermia) (El-Radhi 
AS. & Carroll JE., 1994). Hyperthermia may coexist with fever. 
Previous studies have suggested that overheating may be a factor in some 
SIDS (Bacon etal., 1979; Stanton & Scott, 1980). Several investigators have 
undertaken studies to look for evidence to explain this association. Jardine and 
Haschke used the animal model of weaning piglets to test the hypothesis for severe 
hyperthermia to develop if an infant is unable to remove his blankets in response to 
overheating (thermal entrapment). The results show that it is possible for febrile 
piglets to rapidly expire from severe hyperthermia caused by excessive 
accumulation of endogenously produced heat (thermal entrapment) (Jardine & 
Haschke, 1992). Similar results were reported by Galland in 1997. In this paper, it 
was shown that hyperthermia secondary to covering of the head with bedding can 
lead to death in neonatal piglets (Galland et al, 1997). 
Infection is another risk factor identified for SIDS. Some parents of SIDS 
have reported major symptoms suggesting an infective illness more commonly on 
the days before SIDS than in a control population (Stanton, 1984). It seems that the 
stress ofinfection or an unusually warm environment converted a potential danger 
into a lethal disadvantage (Stanton, 1984). 
Lindgren reported that respiratory syncytial virus infected infants had a 
significantly reinforced reflex apnoea response compared with non-infected infants 
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(Lindgren & Grogaard，1996). IL-lp injected intravenously or intrathecally in 
piglets increases the reflex apnoea response (Stoltenberg et al., 1994). 
Our study showed as expected that hyperthermia significantly increase the mortality 
rate in neonatal rats (Kaplan-Meier p=0.000). Administration ofMDP showed a 
borderline significant increase in mortality rate (Kaplan-Meier p=0.072). 
Using a Cox regression analysis to assess the effects ofMDP (simulating infection) 
and hyperthermia there was a significant effect of the MDP on mortality (Cox 
Regression p=0.016). 
4.6 Furtherstudy 
This study has indicated that the hyperthermia and MDP can influence the 
production of the cytokine IL-ip and IL-6. Hyperthermia itself, or hyperthermia 
combined with MDP, significantly increased the mortality in the neonatal rats. 
The limitations of the study discussed mainly related to difficulties in 
establishing this animal model. These difficulties including the selection of animal, 
best age of animal, not being able to take frequent blood samples, and not being able 
to measure the sleep state and other physiological parameters easily in the neonatal 
rats. It is likely that these limitations may result in the loss of some important and 
useful data. A larger animal model such as the piglet may thus serve as a more 
useful model for further research on investigate the mechanism of SH)S. However 
further development of this neonatal rat model should still be considered as it 
continues to offer a number of potential advantages such as the cost, easy to handle 
and availability ofELISA kits to measure cytokines. 
The main problem with the model established related to difficulties with 
temperature calibration and obtaining uniform readings from all temperature 
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sensors. This problem should be solvable with further technical expertise and input. 
However the problems with temperature measurements will not affect the 
interpretation of the cytokine results as these can be viewed from the perspective of 
relative temperature differences rather than absolute temperatures. 
Other problems with the model related to difficulties in recording a range of 
physiological parameters in the neonatal rat. To establish whether suitable 
transducers for measurement of physiological parameters can be located would need 
to explored if the model is to be used fiirther and if it is considered desirable to 
measure these parameters. 
Alternatively it may be possible to develop an even less invasive neonatal rat 
model. If the neonatal rat could be consistently heated to a moderate non-lethal 
temperature of38 °C or 3 9 � C without anaesthesia and without direct monitoring, it 
might be possible to study the interaction of moderate hyperthermia, MDP and 
hypoxia/hypercarbia on activity, sleep and cytokine production. 
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5.1 Small animal model of hyperthermia 
Setting up this model required selection of the animal, determining the age of animal 
to use, establishing a method of producing hyperthermia with the Temperature 
Controller and recording the data on the PowerLab system. The process of setting up 
a small animal model was reasonably successful, although the model still had a 
number of problems and limitations. 
5.2 Hyperthermia and MDP elicit cytokine response 
Hyperthermia had an effect on the production ofIL-6 and pre-treatment with MDP 
had an effect on the production ofIL-lp. Anaesthesia and direct cardiac puncture 
did not appear to have an effect on the production of either IL-lp or JL-6. 
5.3 Hyperthermia and MDP increase mortality rate 
Hyperthermia, or hyperthermia in combination with infection (MDP), significantly 
increased the mortality rate in neonatal rat. Although hyperthermia of this level 
would be expected to increase mortality, the effect ofMDP indicates that the 
presence of infection in this situation may be important. Further studies exploring 
the interaction between hyperthermia, infection, sleep state and arousal may lead to 
a better understanding of possible mechanism(s) of SIDS. 
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Appendix 1: Experimental record 
Experiment-
Date Duration hours Outcome 
Animal Data: 
Age days Sex Body weight: A gram 
B gram 
Anaesthesia: 
Intraperitoneum injection with ketamine at a dose of 55 mg/kg 
IP: A ml, B ml dilute solution 
T (change over) = for 1 hour T1 = T2 = 
T (change over) 二 for another 1 hour 
Blood Sample 
Blood taken by directly cardiac puncture with syringe 
The blood volume is: A ml, B ml 
Postmortem Examination 
Haemorrhage 
A. None ( ) Lung ( ) Thymus ( ) Kidney ( ) 
Liver ( ) 
0 = no bleeding 1 = occasional bleeding 2 = moderate bleeding 
3 二 severe bleeding 
Appendix 






















2. Rapid regular 
3 • Rapid irregular 
4. Slow regular 





Appendix 2 : Planned Study Timetable 
WEEK 1 
MON TUE WED THU FRI 
01C1 01C2 - 01C3 01T1 
01T2 01T3 - 01T4 01T1M 
01T2M 01T3M - 01T4M -
WEEK 2 
MON TUE WED THU FRI 
02C2 02C3 - 02T1 02T2 
02T3 02T4 - 02TlM 02T2M 
02T3M 02T4M - 02C1 -
WEEK 3 
MON TUE WED THU FRI 
03C3 03T1 - 03T2 03T3 
03T4 03T1M - 03T2M 03T3M 
03T4M 03C1 - 03C2 -
WEEK 4 
MON TUE WED THU FRI 
04T1 04T2 - 04T3 04T4 
04T1M 04T2M - 04T3M 04T4M 
04C1 04C2 - 04C3 -
WEEK 5 
MON TUE WED THU FRI 
05T2 05T3 - 05T4 05T1M 
05T2M 05T3M - 05T4M 05C1 
05C2 05C3 - - 05T1 
WEEK 6 
MON TUE WED THU FRI 
06T3 06T4 - 06T1M 06T2M 
06T3M 06T4M - 06C1 06C2 




MON TUE WED THU FRI 
07T4 07T1M - 07T2M 07T3M 
07T4M 07C1 - 07C2 07C3 
- 07T1 - 07T2 07T3 
WEEK 8 
MON TUE WED THU FRI 
08T1M 08T2M - 08T3M 08T4M 
08C1 08C2 - 08C3 08T1 
08T2 08T3 - 08T4 
WEEK 9 
MON TUE WED THU FRI 
09T2M 09T3M - 09T4M 09C1 
09C2 09C3 - 09T1 09T2 
09T3 09T4 - - 09T1M 
WEEK 10 
MON TUE WED THU FRI 
10T3M 10T4M - 10C1 10C2 
10C3 10T1 - 10T2 10T3 
10T4 - - 10T1M 10T2M 
WEEK 11 
MON TUE WED THU FRI 
01T5 04T5 - 08T5 — 
02T5 06T5 - 09T5 -
03T5 07T5 - 10T5 — 
WEEK 12 
MON TUE WED THU FRI 
01TM5 04TM5 - 08TM5 -
02TM5 06TM5 - 09TM5 -
03TM5 07TM5 - 10TM5 -
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Appendix 
Appendix 3: PowerLab System 
The MacLab system is an easy-to- use continuous data recording solution for both 
life and physical sciences. It is a digital chart recorder, X-Y plotter, storage 
oscilloscope for biochemistry, biology, chemistry, neurophysiology, pharmacology, 
physiology, psychology, zoology. 
This system comprises hardware and software for use on Mac and PC 
platform, Standard features include real-time polygraphic display of experimental 
data, fast data manipulation, on-line computation on multiple input channels, 
convenient file storage and report standard data and result presentation and graphics. 
MacLab have produced an multi-channel data recorder capable of sampling up to 
lOOKHz or as low as 12 samples per hour. The system can be connected to any 
application supplying a signal from 2mV to lOV. This range can be extended by 
attaching amplifiers to record very weak signals. There are MacLab model with 2, 4, 
8 or 16 channels to suit requirements. Data can be recorded , viewed and analysed in 
real time on the computer. It can be printed and stored for reference or later analysis. 
In our study, we select MacLab E series. It is suitable for measuring heart rate, 
blood pressure, temperature, ECG, respiratory fonction. This E series is available in 
a two, four and eight channel models, and offers continuous recording at up to 1000 
samples per second. The series available in three configurations - the MacLab/2e 
with two differential inputs, the MacLab/4e with four differential inputs, and the 
MacLab/8e with eight single-ended inputs. 
MacLab laboratory comprises software, front-ends, transducers and accessories. 
MacLab Front-ends 
MacLab front-ends are advanced signal conditioners that are designed to integrate 
E 
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fully with MacLab software. Front-ends are designed to extend the recording 
capability ofthe MacLab system into specialised fields and applications; they accept 
inputs from a varity of tranducers. The modular approach ofMacLab front-ends 
allows the researcher to customise MacLab easily and at a much smaller outlay than 
alternative conventional approaches. All controls for a particular front-end are 
provided in one easy-to-use dialog box combining filtering and other special 
features. All settings are fully software-controlled, eliminating knobs, dials, and 
switches, and letting you store settings for easy replication ofexperimental set-ups. 
MacLab Accessories 
These include clips, electrodes, cables, tubing, filters etc. 
MacLab Transducers 
Along with the MacLab units and front-ends, there is also a range ofspecialised 
transducers. These transducers are preconfigured to work with MacLab fronts-ends. 
No adjustments need to be made and no wiring is required, you just plug them in 
and use them. The MacLab transducer range includes transducers for measuring 
force, displacement, pressure, temperature, PH, air flow, pulse, respiratory 
movements, and GSR. 
Bioprobe Temperature Sensors (PowerLab system) 
Electrical Specification: Measurement range -50 to 1000 °C 
Environmental Specification: Ambient operating range (0 to 50°C). Basic Accuracy 
at 23 土 5°C ambient: at range -20 to 350�C the accuracy 土 O.5o/o ofreading + 2�C 
(applies for one year after purchase or recalibration) 
Bead Probe: 4 foot K-type thermocouple bead probe with Teflon tape insulation. 
Maximum insulation temperature: 260 °C. Accuracy : + 2.2°C or 士 0.75o/o 
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